activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1790369	CHEMBL856395	Percent residual activity, relative to control, of MAPKAP-K3 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	69.0	CHEMBL4670	Homo sapiens	Activity	%	69.0
	1790369	CHEMBL856395	Percent residual activity, relative to control, of MAPKAP-K3 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	69.0	CHEMBL4670	Homo sapiens	Activity	%	69.0
	1790423	CHEMBL856395	Percent residual activity, relative to control, of MAPKAP-K3 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	67.0	CHEMBL4670	Homo sapiens	Activity	%	67.0
	1824629	CHEMBL915349	Inhibition of MK3	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	Ki	uM	10.0
	1824741	CHEMBL915349	Inhibition of MK3	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	Ki	uM	10.0
	1824822	CHEMBL915349	Inhibition of MK3	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	Ki	uM	10.0
	1881811	CHEMBL904790	Inhibition of MK3	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	57700.0	CHEMBL4670	Homo sapiens	IC50	uM	57.7
	1881818	CHEMBL904790	Inhibition of MK3	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4)c3)cc21		CHEMBL388566	=	IC50	nM	660.0	CHEMBL4670	Homo sapiens	IC50	uM	0.66
	1881825	CHEMBL904790	Inhibition of MK3	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	IC50	nM	210.0	CHEMBL4670	Homo sapiens	IC50	uM	0.21
	1881835	CHEMBL904790	Inhibition of MK3	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	1100.0	CHEMBL4670	Homo sapiens	IC50	uM	1.1
	1981766	CHEMBL899283	Inhibition of MAPKAP K3 assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	97.0	CHEMBL4670	Homo sapiens	Activity	%	97.0
	1981767	CHEMBL899284	Inhibition of MAPKAP K3 assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	91.0	CHEMBL4670	Homo sapiens	Activity	%	91.0
	1983106	CHEMBL899448	Activity against human MAPK3	B	C[C@H]1CN(c2ccc(C(=O)Nc3ccccc3N)cn2)CCN1C(=O)OCc1ccccc1		CHEMBL236902	=	IC50	nM	4520.0	CHEMBL4670	Homo sapiens	IC50	uM	4.52
	2036344	CHEMBL922890	Inhibition of MK3	B	COc1ccc2[nH]c3c(c2c1)CCNC3C(=O)O	Outside typical range	CHEMBL395157	>	IC50	nM	200000.0	CHEMBL4670	Homo sapiens	IC50	uM	200.0
	2036398	CHEMBL922890	Inhibition of MK3	B	COc1ccc2[nH]c3c(c2c1)C1CCN(C1)C3C(=O)O		CHEMBL392876	=	IC50	nM	90000.0	CHEMBL4670	Homo sapiens	IC50	uM	90.0
	2036405	CHEMBL922890	Inhibition of MK3	B	COc1ccc2[nH]c3c(c2c1)C1CCCN(C1)C3C(=O)O	Outside typical range	CHEMBL394124	=	IC50	nM	160000.0	CHEMBL4670	Homo sapiens	IC50	uM	160.0
	2051643	CHEMBL941780	Inhibition of MK3	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	9234.0	CHEMBL4670	Homo sapiens	Ki	uM	9.234
	2081803	CHEMBL928827	Inhibition of MAPKAP-K3 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL4670	Homo sapiens	Inhibition	%	20.0
	2147304	CHEMBL921989	Activity of human MAPKAP-K3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	104.0	CHEMBL4670	Homo sapiens	Activity	%	104.0
	2182822	CHEMBL941448	Inhibition of MAPK3 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	-3.0	CHEMBL4670	Homo sapiens	INH	%	-3.0
	2206783	CHEMBL966741	Inhibition of MK3	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	uM	10.0
Not Active	2302184	CHEMBL950853	Inhibition of MAPKAP-K3 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL4670	Homo sapiens	INH		
	2635907	CHEMBL1003337	Inhibition of MAPKAP-K3 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL4670	Homo sapiens	Residual_activity	%	100.0
	2635975	CHEMBL1003337	Inhibition of MAPKAP-K3 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL4670	Homo sapiens	Residual_activity	%	100.0
	2636043	CHEMBL1003337	Inhibition of MAPKAP-K3 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	100.0	CHEMBL4670	Homo sapiens	Residual_activity	%	100.0
	2721646	CHEMBL1057475	Inhibition of MAPKAP-K3 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	2905804	CHEMBL1063755	Percentage MAPKAPK3 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	103.0	CHEMBL4670	Homo sapiens	Activity	%	103.0
	2905805	CHEMBL1063755	Percentage MAPKAPK3 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	91.0	CHEMBL4670	Homo sapiens	Activity	%	91.0
	2905806	CHEMBL1063755	Percentage MAPKAPK3 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	107.0	CHEMBL4670	Homo sapiens	Activity	%	107.0
	2905807	CHEMBL1063756	Percentage MAPKAPK3 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	108.0	CHEMBL4670	Homo sapiens	Activity	%	108.0
	2905808	CHEMBL1063756	Percentage MAPKAPK3 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	102.0	CHEMBL4670	Homo sapiens	Activity	%	102.0
	2905809	CHEMBL1063756	Percentage MAPKAPK3 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	96.0	CHEMBL4670	Homo sapiens	Activity	%	96.0
	2905810	CHEMBL1063756	Percentage MAPKAPK3 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	88.0	CHEMBL4670	Homo sapiens	Activity	%	88.0
	2905811	CHEMBL1063756	Percentage MAPKAPK3 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	90.0	CHEMBL4670	Homo sapiens	Activity	%	90.0
	2905812	CHEMBL1063756	Percentage MAPKAPK3 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	95.0	CHEMBL4670	Homo sapiens	Activity	%	95.0
	2905813	CHEMBL1063756	Percentage MAPKAPK3 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	90.0	CHEMBL4670	Homo sapiens	Activity	%	90.0
	2905814	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	84.0	CHEMBL4670	Homo sapiens	Activity	%	84.0
	2905815	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	114.0	CHEMBL4670	Homo sapiens	Activity	%	114.0
	2905816	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	82.0	CHEMBL4670	Homo sapiens	Activity	%	82.0
	2905817	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	77.0	CHEMBL4670	Homo sapiens	Activity	%	77.0
	2905818	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	98.0	CHEMBL4670	Homo sapiens	Activity	%	98.0
	2905819	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	94.0	CHEMBL4670	Homo sapiens	Activity	%	94.0
	2905820	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	119.0	CHEMBL4670	Homo sapiens	Activity	%	119.0
	2905821	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	96.0	CHEMBL4670	Homo sapiens	Activity	%	96.0
	2905822	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	56.0	CHEMBL4670	Homo sapiens	Activity	%	56.0
	2905823	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	98.0	CHEMBL4670	Homo sapiens	Activity	%	98.0
	2905824	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	99.0	CHEMBL4670	Homo sapiens	Activity	%	99.0
	2905825	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	90.0	CHEMBL4670	Homo sapiens	Activity	%	90.0
	2905826	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	102.0	CHEMBL4670	Homo sapiens	Activity	%	102.0
	2905827	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	100.0	CHEMBL4670	Homo sapiens	Activity	%	100.0
	2905828	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	92.0	CHEMBL4670	Homo sapiens	Activity	%	92.0
	2905829	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	88.0	CHEMBL4670	Homo sapiens	Activity	%	88.0
	2905830	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	94.0	CHEMBL4670	Homo sapiens	Activity	%	94.0
	2905831	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	105.0	CHEMBL4670	Homo sapiens	Activity	%	105.0
	2905832	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	92.0	CHEMBL4670	Homo sapiens	Activity	%	92.0
	2905833	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	112.0	CHEMBL4670	Homo sapiens	Activity	%	112.0
	2905834	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	95.0	CHEMBL4670	Homo sapiens	Activity	%	95.0
	2905835	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	97.0	CHEMBL4670	Homo sapiens	Activity	%	97.0
	2905836	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	97.0	CHEMBL4670	Homo sapiens	Activity	%	97.0
	2905837	CHEMBL1060201	Percentage MAPKAPK3 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	71.0	CHEMBL4670	Homo sapiens	Activity	%	71.0
	2905838	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	89.0	CHEMBL4670	Homo sapiens	Activity	%	89.0
	2905839	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	71.0	CHEMBL4670	Homo sapiens	Activity	%	71.0
	2905840	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	88.0	CHEMBL4670	Homo sapiens	Activity	%	88.0
Antagonist	2905841	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	16.0	CHEMBL4670	Homo sapiens	Activity	%	16.0
	2905842	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	87.0	CHEMBL4670	Homo sapiens	Activity	%	87.0
	2905843	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	103.0	CHEMBL4670	Homo sapiens	Activity	%	103.0
	2905844	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	104.0	CHEMBL4670	Homo sapiens	Activity	%	104.0
	2905845	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	120.0	CHEMBL4670	Homo sapiens	Activity	%	120.0
	2905846	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	104.0	CHEMBL4670	Homo sapiens	Activity	%	104.0
	2905847	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	98.0	CHEMBL4670	Homo sapiens	Activity	%	98.0
	2905848	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	86.0	CHEMBL4670	Homo sapiens	Activity	%	86.0
	2905849	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	70.0	CHEMBL4670	Homo sapiens	Activity	%	70.0
	2905850	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	97.0	CHEMBL4670	Homo sapiens	Activity	%	97.0
	2905851	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	102.0	CHEMBL4670	Homo sapiens	Activity	%	102.0
	2905852	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	103.0	CHEMBL4670	Homo sapiens	Activity	%	103.0
	2905853	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	105.0	CHEMBL4670	Homo sapiens	Activity	%	105.0
	2905854	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	98.0	CHEMBL4670	Homo sapiens	Activity	%	98.0
	2905855	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	99.0	CHEMBL4670	Homo sapiens	Activity	%	99.0
	2905856	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	104.0	CHEMBL4670	Homo sapiens	Activity	%	104.0
	2905857	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	97.0	CHEMBL4670	Homo sapiens	Activity	%	97.0
	2905858	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	95.0	CHEMBL4670	Homo sapiens	Activity	%	95.0
	2905859	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	105.0	CHEMBL4670	Homo sapiens	Activity	%	105.0
	2905860	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	107.0	CHEMBL4670	Homo sapiens	Activity	%	107.0
	2906720	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	105.0	CHEMBL4670	Homo sapiens	Activity	%	105.0
	2906721	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	96.0	CHEMBL4670	Homo sapiens	Activity	%	96.0
	2906722	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	88.0	CHEMBL4670	Homo sapiens	Activity	%	88.0
	2906723	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	86.0	CHEMBL4670	Homo sapiens	Activity	%	86.0
	2906724	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	98.0	CHEMBL4670	Homo sapiens	Activity	%	98.0
	2906725	CHEMBL1060202	Percentage MAPKAPK3 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	94.0	CHEMBL4670	Homo sapiens	Activity	%	94.0
	2906726	CHEMBL1060202	Percentage MAPKAPK3 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	86.0	CHEMBL4670	Homo sapiens	Activity	%	86.0
	2906727	CHEMBL1061218	Percentage MAPKAPK3 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	103.0	CHEMBL4670	Homo sapiens	Activity	%	103.0
	2906728	CHEMBL1060142	Percentage MAPKAPK3 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	92.0	CHEMBL4670	Homo sapiens	Activity	%	92.0
	2907067	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	102.0	CHEMBL4670	Homo sapiens	Activity	%	102.0
	2907068	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	91.0	CHEMBL4670	Homo sapiens	Activity	%	91.0
	2907069	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	101.0	CHEMBL4670	Homo sapiens	Activity	%	101.0
	2907070	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	96.0	CHEMBL4670	Homo sapiens	Activity	%	96.0
	2907071	CHEMBL1061148	Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	104.0	CHEMBL4670	Homo sapiens	Activity	%	104.0
	2924773	CHEMBL1056866	Inhibition of MAPKAPK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	88.0	CHEMBL4670	Homo sapiens	Activity	%	88.0
	2924774	CHEMBL1056866	Inhibition of MAPKAPK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	89.0	CHEMBL4670	Homo sapiens	Activity	%	89.0
	2924775	CHEMBL1056866	Inhibition of MAPKAPK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	90.0	CHEMBL4670	Homo sapiens	Activity	%	90.0
	2924776	CHEMBL1056866	Inhibition of MAPKAPK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	69.0	CHEMBL4670	Homo sapiens	Activity	%	69.0
	2938486	CHEMBL1041379	Inhibition of MAPKAPK3 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	5.0	CHEMBL4670	Homo sapiens	INH	%	5.0
	2999006	CHEMBL1041978	Inhibition of MAPKAPK3 assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	104.0	CHEMBL4670	Homo sapiens	Activity	%	104.0
	2999796	CHEMBL1041978	Inhibition of MAPKAPK3 assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	113.0	CHEMBL4670	Homo sapiens	Activity	%	113.0
	3052650	CHEMBL1041137	Residual activity of MAPKAPK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	98.0	CHEMBL4670	Homo sapiens	Residual activity	%	98.0
	3053959	CHEMBL1050290	Residual activity of MAPKAPK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	42.0	CHEMBL4670	Homo sapiens	Residual activity	%	42.0
	3054211	CHEMBL1040679	Residual activity of MAPKAPK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	91.0	CHEMBL4670	Homo sapiens	Residual activity	%	91.0
	3055498	CHEMBL1041137	Residual activity of MAPKAPK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	85.0	CHEMBL4670	Homo sapiens	Residual activity	%	85.0
	3056803	CHEMBL1050290	Residual activity of MAPKAPK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	41.0	CHEMBL4670	Homo sapiens	Residual activity	%	41.0
	3057055	CHEMBL1040679	Residual activity of MAPKAPK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL4670	Homo sapiens	Residual activity	%	93.0
	3058375	CHEMBL1041137	Residual activity of MAPKAPK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	94.0	CHEMBL4670	Homo sapiens	Residual activity	%	94.0
	3058627	CHEMBL1050290	Residual activity of MAPKAPK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	67.0	CHEMBL4670	Homo sapiens	Residual activity	%	67.0
	3072973	CHEMBL1040679	Residual activity of MAPKAPK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	94.0	CHEMBL4670	Homo sapiens	Residual activity	%	94.0
	3084408	CHEMBL1072687	Inhibition of MK3	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	3800.0	CHEMBL4670	Homo sapiens	IC50	uM	3.8
	3130802	CHEMBL1065091	Inhibition of MAPKAPK3 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	3131762	CHEMBL1065766	Inhibition of MAPKAPK3 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	3213958	CHEMBL1116706	Inhibition of MAPKAPK3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	3.0	CHEMBL4670	Homo sapiens	INH	%	3.0
	3224879	CHEMBL1100957	Inhibition of MAPKAPK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	3225129	CHEMBL1100957	Inhibition of MAPKAPK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	3240818	CHEMBL1109705	Inhibition of MK3	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL4670	Homo sapiens	IC50	uM	1.0
	3260072	CHEMBL1104319	Inhibition of MAPKAPK-3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	72.0	CHEMBL4670	Homo sapiens	Activity	%	72.0
	3261401	CHEMBL1104319	Inhibition of MAPKAPK-3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	81.0	CHEMBL4670	Homo sapiens	Activity	%	81.0
	3306939	CHEMBL1118063	Inhibition of MAPKAPK3 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	94.0	CHEMBL4670	Homo sapiens	INH	%	94.0
	3443448	CHEMBL1244214	Inhibition of MAPKAPK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	-1.0	CHEMBL4670	Homo sapiens	INH	%	-1.0
	3443665	CHEMBL1244214	Inhibition of MAPKAPK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	-2.0	CHEMBL4670	Homo sapiens	INH	%	-2.0
	3444820	CHEMBL1244214	Inhibition of MAPKAPK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	-1.0	CHEMBL4670	Homo sapiens	INH	%	-1.0
	3445444	CHEMBL1244214	Inhibition of MAPKAPK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-1.0	CHEMBL4670	Homo sapiens	INH	%	-1.0
	3445661	CHEMBL1244214	Inhibition of MAPKAPK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	8.0	CHEMBL4670	Homo sapiens	INH	%	8.0
	3445864	CHEMBL1244214	Inhibition of MAPKAPK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	10.0	CHEMBL4670	Homo sapiens	INH	%	10.0
	3446054	CHEMBL1244214	Inhibition of MAPKAPK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	4.0	CHEMBL4670	Homo sapiens	INH	%	4.0
	3463282	CHEMBL1252485	Inhibition of MAPKAPK3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	2.0	CHEMBL4670	Homo sapiens	INH	%	2.0
	3463826	CHEMBL1252485	Inhibition of MAPKAPK3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	11.0	CHEMBL4670	Homo sapiens	INH	%	11.0
	3464045	CHEMBL1252485	Inhibition of MAPKAPK3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	10.0	CHEMBL4670	Homo sapiens	INH	%	10.0
	5121122	CHEMBL1646190	Inhibition of human MAPKAP-K3 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	112.0	CHEMBL4670	Homo sapiens	INH	%	112.0
	5133672	CHEMBL1648740	Inhibition of MAPKAPK3 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	75.0	CHEMBL4670	Homo sapiens	Activity	%	75.0
	5133767	CHEMBL1648740	Inhibition of MAPKAPK3 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	96.0	CHEMBL4670	Homo sapiens	Activity	%	96.0
	5133904	CHEMBL1648740	Inhibition of MAPKAPK3 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	91.0	CHEMBL4670	Homo sapiens	Activity	%	91.0
	6202203	CHEMBL1780657	Inhibition of MK3 at 1 uM	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779369	>=	Inhibition	%	95.0	CHEMBL4670	Homo sapiens	INH	%	95.0
	6202204	CHEMBL1780657	Inhibition of MK3 at 1 uM	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779370	>=	Inhibition	%	95.0	CHEMBL4670	Homo sapiens	INH	%	95.0
	6262764	CHEMBL1798987	Inhibition of MK3	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	uM	10.0
	6352231	CHEMBL1825838	Inhibition of MAPKAP-K3 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	89.0	CHEMBL4670	Homo sapiens	Activity	%	89.0
	7961051	CHEMBL1932888	Inhibition of MAPKAPK3	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4670	Homo sapiens	IC50	uM	30.0
	7961052	CHEMBL1932888	Inhibition of MAPKAPK3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4670	Homo sapiens	IC50	uM	30.0
	7969744	CHEMBL1931443	Inhibition of MAPKAP-K3 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	84.0	CHEMBL4670	Homo sapiens	Activity	%	84.0
	8018828	CHEMBL1948948	Inhibition of MAPKAP-K3 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	94.0	CHEMBL4670	Homo sapiens	Activity	%	94.0
Not Determined	8018829	CHEMBL1948948	Inhibition of MAPKAP-K3 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950		Activity			CHEMBL4670	Homo sapiens	Activity		
Not Determined	8018830	CHEMBL1948948	Inhibition of MAPKAP-K3 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262		Activity			CHEMBL4670	Homo sapiens	Activity		
	8061266	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	15.48	CHEMBL4670	Homo sapiens	Inhibition	%	15.48
	8061443	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.92	CHEMBL4670	Homo sapiens	Inhibition	%	-1.92
	8061774	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	36.93	CHEMBL4670	Homo sapiens	Inhibition	%	36.93
	8061965	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.19	CHEMBL4670	Homo sapiens	Inhibition	%	2.19
	8062189	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.11	CHEMBL4670	Homo sapiens	Inhibition	%	5.11
	8062305	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.29	CHEMBL4670	Homo sapiens	Inhibition	%	3.29
	8062691	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.98	CHEMBL4670	Homo sapiens	Inhibition	%	3.98
	8062789	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.7	CHEMBL4670	Homo sapiens	Inhibition	%	1.7
	8063013	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.61	CHEMBL4670	Homo sapiens	Inhibition	%	2.61
	8063145	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	30.88	CHEMBL4670	Homo sapiens	Inhibition	%	30.88
	8063312	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.41	CHEMBL4670	Homo sapiens	Inhibition	%	4.41
	8063536	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	17.35	CHEMBL4670	Homo sapiens	Inhibition	%	17.35
	8063644	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.61	CHEMBL4670	Homo sapiens	Inhibition	%	3.61
	8064050	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	12.31	CHEMBL4670	Homo sapiens	Inhibition	%	12.31
	8064165	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.75	CHEMBL4670	Homo sapiens	Inhibition	%	2.75
	8064389	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.53	CHEMBL4670	Homo sapiens	Inhibition	%	2.53
	8064599	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.12	CHEMBL4670	Homo sapiens	Inhibition	%	3.12
	8064737	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.05	CHEMBL4670	Homo sapiens	Inhibition	%	0.05
	8065127	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.44	CHEMBL4670	Homo sapiens	Inhibition	%	1.44
	8065243	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.05	CHEMBL4670	Homo sapiens	Inhibition	%	5.05
	8065467	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.95	CHEMBL4670	Homo sapiens	Inhibition	%	4.95
	8065642	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	31.9	CHEMBL4670	Homo sapiens	Inhibition	%	31.9
	8065981	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.85	CHEMBL4670	Homo sapiens	Inhibition	%	2.85
	8066191	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.57	CHEMBL4670	Homo sapiens	Inhibition	%	0.57
	8066327	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.81	CHEMBL4670	Homo sapiens	Inhibition	%	0.81
	8066551	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.44	CHEMBL4670	Homo sapiens	Inhibition	%	0.44
	8066717	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.8	CHEMBL4670	Homo sapiens	Inhibition	%	3.8
	8067065	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	6.43	CHEMBL4670	Homo sapiens	Inhibition	%	6.43
	8067240	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.8	CHEMBL4670	Homo sapiens	Inhibition	%	1.8
	8067585	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	14.36	CHEMBL4670	Homo sapiens	Inhibition	%	14.36
	8067795	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.5	CHEMBL4670	Homo sapiens	Inhibition	%	2.5
	8068154	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.56	CHEMBL4670	Homo sapiens	Inhibition	%	0.56
	8068318	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.02	CHEMBL4670	Homo sapiens	Inhibition	%	-0.02
	8068667	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.8	CHEMBL4670	Homo sapiens	Inhibition	%	0.8
	8068841	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.35	CHEMBL4670	Homo sapiens	Inhibition	%	3.35
	8069065	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.16	CHEMBL4670	Homo sapiens	Inhibition	%	2.16
	8069190	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	28.41	CHEMBL4670	Homo sapiens	Inhibition	%	28.41
	8069485	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.86	CHEMBL4670	Homo sapiens	Inhibition	%	0.86
	8069646	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.79	CHEMBL4670	Homo sapiens	Inhibition	%	2.79
	8069870	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.78	CHEMBL4670	Homo sapiens	Inhibition	%	0.78
	8069996	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.7	CHEMBL4670	Homo sapiens	Inhibition	%	0.7
	8070392	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.35	CHEMBL4670	Homo sapiens	Inhibition	%	2.35
	8070517	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.63	CHEMBL4670	Homo sapiens	Inhibition	%	0.63
	8070815	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.23	CHEMBL4670	Homo sapiens	Inhibition	%	2.23
	8071196	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.25	CHEMBL4670	Homo sapiens	Inhibition	%	2.25
	8071322	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.58	CHEMBL4670	Homo sapiens	Inhibition	%	0.58
	8071546	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.89	CHEMBL4670	Homo sapiens	Inhibition	%	2.89
	8071719	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.91	CHEMBL4670	Homo sapiens	Inhibition	%	2.91
	8071844	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	6.51	CHEMBL4670	Homo sapiens	Inhibition	%	6.51
	8072068	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	7.74	CHEMBL4670	Homo sapiens	Inhibition	%	7.74
	8072158	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	Inhibition	%	0.0
	8072382	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.82	CHEMBL4670	Homo sapiens	Inhibition	%	1.82
	8072539	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.74	CHEMBL4670	Homo sapiens	Inhibition	%	1.74
	8072888	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.65	CHEMBL4670	Homo sapiens	Inhibition	%	-1.65
	8073055	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.6	CHEMBL4670	Homo sapiens	Inhibition	%	3.6
	8073404	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	20.29	CHEMBL4670	Homo sapiens	Inhibition	%	20.29
	8073523	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.9	CHEMBL4670	Homo sapiens	Inhibition	%	2.9
	8073747	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.35	CHEMBL4670	Homo sapiens	Inhibition	%	1.35
	8073980	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.48	CHEMBL4670	Homo sapiens	Inhibition	%	-1.48
	8074132	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.32	CHEMBL4670	Homo sapiens	Inhibition	%	2.32
	8074486	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.87	CHEMBL4670	Homo sapiens	Inhibition	%	0.87
	8074643	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	13.44	CHEMBL4670	Homo sapiens	Inhibition	%	13.44
	8074994	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.09	CHEMBL4670	Homo sapiens	Inhibition	%	-0.09
	8075329	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.13	CHEMBL4670	Homo sapiens	Inhibition	%	3.13
	8075566	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.59	CHEMBL4670	Homo sapiens	Inhibition	%	-0.59
	8075707	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.96	CHEMBL4670	Homo sapiens	Inhibition	%	2.96
	8075931	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.57	CHEMBL4670	Homo sapiens	Inhibition	%	3.57
	8076073	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.9	CHEMBL4670	Homo sapiens	Inhibition	%	-0.9
	8076221	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	28.72	CHEMBL4670	Homo sapiens	Inhibition	%	28.72
	8076445	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.1	CHEMBL4670	Homo sapiens	Inhibition	%	2.1
	8076579	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.19	CHEMBL4670	Homo sapiens	Inhibition	%	0.19
	8076905	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	14.48	CHEMBL4670	Homo sapiens	Inhibition	%	14.48
	8077152	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-3.02	CHEMBL4670	Homo sapiens	Inhibition	%	-3.02
	8077504	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.27	CHEMBL4670	Homo sapiens	Inhibition	%	5.27
	8077655	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.93	CHEMBL4670	Homo sapiens	Inhibition	%	-0.93
	8078022	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.28	CHEMBL4670	Homo sapiens	Inhibition	%	4.28
	8078161	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.95	CHEMBL4670	Homo sapiens	Inhibition	%	-0.95
	8078487	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	8.04	CHEMBL4670	Homo sapiens	Inhibition	%	8.04
	8078737	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.47	CHEMBL4670	Homo sapiens	Inhibition	%	-0.47
	8079077	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	16.31	CHEMBL4670	Homo sapiens	Inhibition	%	16.31
	8079235	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.21	CHEMBL4670	Homo sapiens	Inhibition	%	-0.21
	8079459	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.73	CHEMBL4670	Homo sapiens	Inhibition	%	-0.73
	8079601	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.85	CHEMBL4670	Homo sapiens	Inhibition	%	0.85
	8079740	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.99	CHEMBL4670	Homo sapiens	Inhibition	%	-0.99
	8079964	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	5.33	CHEMBL4670	Homo sapiens	Inhibition	%	5.33
	8080069	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	26.95	CHEMBL4670	Homo sapiens	Inhibition	%	26.95
	8080321	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.74	CHEMBL4670	Homo sapiens	Inhibition	%	-2.74
	8080545	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.61	CHEMBL4670	Homo sapiens	Inhibition	%	-2.61
	8080660	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.72	CHEMBL4670	Homo sapiens	Inhibition	%	2.72
	8081048	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	27.57	CHEMBL4670	Homo sapiens	Inhibition	%	27.57
	8081183	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.94	CHEMBL4670	Homo sapiens	Inhibition	%	3.94
	8081551	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	11.91	CHEMBL4670	Homo sapiens	Inhibition	%	11.91
	8081654	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.58	CHEMBL4670	Homo sapiens	Inhibition	%	-0.58
	8081878	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.59	CHEMBL4670	Homo sapiens	Inhibition	%	1.59
	8082130	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.2	CHEMBL4670	Homo sapiens	Inhibition	%	-2.2
	8082243	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.71	CHEMBL4670	Homo sapiens	Inhibition	%	4.71
	8082640	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	34.1	CHEMBL4670	Homo sapiens	Inhibition	%	34.1
	8082763	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	5.84	CHEMBL4670	Homo sapiens	Inhibition	%	5.84
	8082987	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	18.89	CHEMBL4670	Homo sapiens	Inhibition	%	18.89
	8083143	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.93	CHEMBL4670	Homo sapiens	Inhibition	%	9.93
	8083466	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.07	CHEMBL4670	Homo sapiens	Inhibition	%	-0.07
	8083720	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.76	CHEMBL4670	Homo sapiens	Inhibition	%	-2.76
	8083830	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	17.08	CHEMBL4670	Homo sapiens	Inhibition	%	17.08
	8084054	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	33.55	CHEMBL4670	Homo sapiens	Inhibition	%	33.55
	8084239	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.79	CHEMBL4670	Homo sapiens	Inhibition	%	2.79
	8084581	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.73	CHEMBL4670	Homo sapiens	Inhibition	%	2.73
	8084742	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	10.63	CHEMBL4670	Homo sapiens	Inhibition	%	10.63
	8085064	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.93	CHEMBL4670	Homo sapiens	Inhibition	%	0.93
	8085320	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.35	CHEMBL4670	Homo sapiens	Inhibition	%	-2.35
	8085652	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	34.84	CHEMBL4670	Homo sapiens	Inhibition	%	34.84
	8085841	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	3.84	CHEMBL4670	Homo sapiens	Inhibition	%	3.84
	8086180	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.81	CHEMBL4670	Homo sapiens	Inhibition	%	2.81
	8086342	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.88	CHEMBL4670	Homo sapiens	Inhibition	%	2.88
	8086566	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.79	CHEMBL4670	Homo sapiens	Inhibition	%	2.79
	8086665	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.85	CHEMBL4670	Homo sapiens	Inhibition	%	0.85
	8086876	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.14	CHEMBL4670	Homo sapiens	Inhibition	%	2.14
	8087100	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.96	CHEMBL4670	Homo sapiens	Inhibition	%	1.96
	8087258	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.24	CHEMBL4670	Homo sapiens	Inhibition	%	6.24
	8087596	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.93	CHEMBL4670	Homo sapiens	Inhibition	%	0.93
	8087734	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.01	CHEMBL4670	Homo sapiens	Inhibition	%	13.01
	8087958	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	31.29	CHEMBL4670	Homo sapiens	Inhibition	%	31.29
	8088100	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	10.7	CHEMBL4670	Homo sapiens	Inhibition	%	10.7
	8088248	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.37	CHEMBL4670	Homo sapiens	Inhibition	%	0.37
	8088472	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.22	CHEMBL4670	Homo sapiens	Inhibition	%	2.22
	8088600	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	9.03	CHEMBL4670	Homo sapiens	Inhibition	%	9.03
	8088917	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.52	CHEMBL4670	Homo sapiens	Inhibition	%	1.52
	8089045	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	10.35	CHEMBL4670	Homo sapiens	Inhibition	%	10.35
	8089269	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.67	CHEMBL4670	Homo sapiens	Inhibition	%	-0.67
	8089417	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	7.64	CHEMBL4670	Homo sapiens	Inhibition	%	7.64
	8089761	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.9	CHEMBL4670	Homo sapiens	Inhibition	%	2.9
	8089941	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	19.86	CHEMBL4670	Homo sapiens	Inhibition	%	19.86
	8090330	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.17	CHEMBL4670	Homo sapiens	Inhibition	%	5.17
	8090497	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.51	CHEMBL4670	Homo sapiens	Inhibition	%	1.51
	8090860	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.5	CHEMBL4670	Homo sapiens	Inhibition	%	2.5
	8091065	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.13	CHEMBL4670	Homo sapiens	Inhibition	%	3.13
	8091426	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.15	CHEMBL4670	Homo sapiens	Inhibition	%	3.15
	8091581	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	20.15	CHEMBL4670	Homo sapiens	Inhibition	%	20.15
	8091921	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.35	CHEMBL4670	Homo sapiens	Inhibition	%	1.35
	8092282	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	33.44	CHEMBL4670	Homo sapiens	Inhibition	%	33.44
	8092433	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.37	CHEMBL4670	Homo sapiens	Inhibition	%	3.37
	8092805	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-4.76	CHEMBL4670	Homo sapiens	Inhibition	%	-4.76
	8092934	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	10.86	CHEMBL4670	Homo sapiens	Inhibition	%	10.86
	8093246	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	30.18	CHEMBL4670	Homo sapiens	Inhibition	%	30.18
	8093610	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-6.12	CHEMBL4670	Homo sapiens	Inhibition	%	-6.12
	8093749	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	7.15	CHEMBL4670	Homo sapiens	Inhibition	%	7.15
	8094093	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.29	CHEMBL4670	Homo sapiens	Inhibition	%	3.29
	8094273	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.42	CHEMBL4670	Homo sapiens	Inhibition	%	1.42
	8094497	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.25	CHEMBL4670	Homo sapiens	Inhibition	%	1.25
	8094672	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.04	CHEMBL4670	Homo sapiens	Inhibition	%	3.04
	8094828	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.12	CHEMBL4670	Homo sapiens	Inhibition	%	1.12
	8095052	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.6	CHEMBL4670	Homo sapiens	Inhibition	%	2.6
	8095192	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	7.62	CHEMBL4670	Homo sapiens	Inhibition	%	7.62
	8095395	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.48	CHEMBL4670	Homo sapiens	Inhibition	%	2.48
	8095760	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.16	CHEMBL4670	Homo sapiens	Inhibition	%	6.16
	8095908	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.95	CHEMBL4670	Homo sapiens	Inhibition	%	6.95
	8096132	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	9.14	CHEMBL4670	Homo sapiens	Inhibition	%	9.14
	8096249	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	14.72	CHEMBL4670	Homo sapiens	Inhibition	%	14.72
	8096612	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	6.01	CHEMBL4670	Homo sapiens	Inhibition	%	6.01
	8096768	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.64	CHEMBL4670	Homo sapiens	Inhibition	%	4.64
	8097139	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-5.22	CHEMBL4670	Homo sapiens	Inhibition	%	-5.22
	8097446	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	36.3	CHEMBL4670	Homo sapiens	Inhibition	%	36.3
	8097670	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	9.72	CHEMBL4670	Homo sapiens	Inhibition	%	9.72
	8097820	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-7.91	CHEMBL4670	Homo sapiens	Inhibition	%	-7.91
	8097953	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.86	CHEMBL4670	Homo sapiens	Inhibition	%	0.86
	8098177	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.42	CHEMBL4670	Homo sapiens	Inhibition	%	-0.42
	8098297	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.28	CHEMBL4670	Homo sapiens	Inhibition	%	2.28
	8098701	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.07	CHEMBL4670	Homo sapiens	Inhibition	%	1.07
	8098886	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.11	CHEMBL4670	Homo sapiens	Inhibition	%	7.11
	8099254	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.32	CHEMBL4670	Homo sapiens	Inhibition	%	1.32
	8099396	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.07	CHEMBL4670	Homo sapiens	Inhibition	%	3.07
	8099590	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	32.72	CHEMBL4670	Homo sapiens	Inhibition	%	32.72
	8099814	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	35.13	CHEMBL4670	Homo sapiens	Inhibition	%	35.13
	8099961	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-0.57	CHEMBL4670	Homo sapiens	Inhibition	%	-0.57
	8100331	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.18	CHEMBL4670	Homo sapiens	Inhibition	%	-0.18
	8100447	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	28.95	CHEMBL4670	Homo sapiens	Inhibition	%	28.95
	8100671	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	13.9	CHEMBL4670	Homo sapiens	Inhibition	%	13.9
	8100811	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	8.71	CHEMBL4670	Homo sapiens	Inhibition	%	8.71
	8100971	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	9.46	CHEMBL4670	Homo sapiens	Inhibition	%	9.46
	8101195	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	12.46	CHEMBL4670	Homo sapiens	Inhibition	%	12.46
	8101337	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.98	CHEMBL4670	Homo sapiens	Inhibition	%	-1.98
	8101522	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.18	CHEMBL4670	Homo sapiens	Inhibition	%	3.18
	8101746	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.49	CHEMBL4670	Homo sapiens	Inhibition	%	2.49
	8101999	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	11.07	CHEMBL4670	Homo sapiens	Inhibition	%	11.07
	8102154	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.55	CHEMBL4670	Homo sapiens	Inhibition	%	-2.55
	8102509	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.95	CHEMBL4670	Homo sapiens	Inhibition	%	1.95
	8102629	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	3.61	CHEMBL4670	Homo sapiens	Inhibition	%	3.61
	8102853	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.57	CHEMBL4670	Homo sapiens	Inhibition	%	0.57
	8103031	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.28	CHEMBL4670	Homo sapiens	Inhibition	%	-0.28
	8103227	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.45	CHEMBL4670	Homo sapiens	Inhibition	%	1.45
	8103589	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.51	CHEMBL4670	Homo sapiens	Inhibition	%	1.51
	8103739	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.6	CHEMBL4670	Homo sapiens	Inhibition	%	2.6
	8103963	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.3	CHEMBL4670	Homo sapiens	Inhibition	%	3.3
	8104148	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	3.71	CHEMBL4670	Homo sapiens	Inhibition	%	3.71
	8104296	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-0.87	CHEMBL4670	Homo sapiens	Inhibition	%	-0.87
	8104520	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.95	CHEMBL4670	Homo sapiens	Inhibition	%	2.95
	8104666	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.48	CHEMBL4670	Homo sapiens	Inhibition	%	-0.48
	8105004	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	30.76	CHEMBL4670	Homo sapiens	Inhibition	%	30.76
	8105144	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	21.68	CHEMBL4670	Homo sapiens	Inhibition	%	21.68
	8105534	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.38	CHEMBL4670	Homo sapiens	Inhibition	%	3.38
	8105672	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.22	CHEMBL4670	Homo sapiens	Inhibition	%	-2.22
	8105896	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.76	CHEMBL4670	Homo sapiens	Inhibition	%	3.76
	8105952	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-4.18	CHEMBL4670	Homo sapiens	Inhibition	%	-4.18
	8106176	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-2.89	CHEMBL4670	Homo sapiens	Inhibition	%	-2.89
	8106341	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	8.23	CHEMBL4670	Homo sapiens	Inhibition	%	8.23
	8106497	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.42	CHEMBL4670	Homo sapiens	Inhibition	%	-2.42
	8106721	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.07	CHEMBL4670	Homo sapiens	Inhibition	%	-1.07
	8106850	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.47	CHEMBL4670	Homo sapiens	Inhibition	%	-0.47
	8107195	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.13	CHEMBL4670	Homo sapiens	Inhibition	%	1.13
	8107367	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.71	CHEMBL4670	Homo sapiens	Inhibition	%	1.71
	8107568	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.95	CHEMBL4670	Homo sapiens	Inhibition	%	2.95
	8107792	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.13	CHEMBL4670	Homo sapiens	Inhibition	%	3.13
	8107927	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.85	CHEMBL4670	Homo sapiens	Inhibition	%	1.85
	8108309	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.78	CHEMBL4670	Homo sapiens	Inhibition	%	2.78
	8108484	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.53	CHEMBL4670	Homo sapiens	Inhibition	%	4.53
	8108855	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.34	CHEMBL4670	Homo sapiens	Inhibition	%	3.34
	8108997	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.36	CHEMBL4670	Homo sapiens	Inhibition	%	-0.36
	8109335	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	41.38	CHEMBL4670	Homo sapiens	Inhibition	%	41.38
	8109465	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	29.99	CHEMBL4670	Homo sapiens	Inhibition	%	29.99
	8109689	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	23.18	CHEMBL4670	Homo sapiens	Inhibition	%	23.18
	8109860	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.91	CHEMBL4670	Homo sapiens	Inhibition	%	3.91
	8110216	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.61	CHEMBL4670	Homo sapiens	Inhibition	%	3.61
	8110495	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.78	CHEMBL4670	Homo sapiens	Inhibition	%	1.78
	8110661	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	22.68	CHEMBL4670	Homo sapiens	Inhibition	%	22.68
	8111043	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.66	CHEMBL4670	Homo sapiens	Inhibition	%	-0.66
	8111166	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-2.74	CHEMBL4670	Homo sapiens	Inhibition	%	-2.74
	8111517	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.39	CHEMBL4670	Homo sapiens	Inhibition	%	-0.39
	8111683	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.9	CHEMBL4670	Homo sapiens	Inhibition	%	-0.9
	8111907	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.49	CHEMBL4670	Homo sapiens	Inhibition	%	2.49
	8112112	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.32	CHEMBL4670	Homo sapiens	Inhibition	%	4.32
	8112249	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.03	CHEMBL4670	Homo sapiens	Inhibition	%	0.03
	8112641	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.0	CHEMBL4670	Homo sapiens	Inhibition	%	6.0
	8112813	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.57	CHEMBL4670	Homo sapiens	Inhibition	%	0.57
	8113189	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.43	CHEMBL4670	Homo sapiens	Inhibition	%	2.43
	8113325	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.16	CHEMBL4670	Homo sapiens	Inhibition	%	2.16
	8113549	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-5.03	CHEMBL4670	Homo sapiens	Inhibition	%	-5.03
	8113673	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	46.33	CHEMBL4670	Homo sapiens	Inhibition	%	46.33
	8114013	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	34.05	CHEMBL4670	Homo sapiens	Inhibition	%	34.05
	8114189	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.88	CHEMBL4670	Homo sapiens	Inhibition	%	5.88
	8114545	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	9.64	CHEMBL4670	Homo sapiens	Inhibition	%	9.64
	8114821	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.53	CHEMBL4670	Homo sapiens	Inhibition	%	4.53
	8114987	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.46	CHEMBL4670	Homo sapiens	Inhibition	%	3.46
	8115376	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	5.56	CHEMBL4670	Homo sapiens	Inhibition	%	5.56
	8115496	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-3.85	CHEMBL4670	Homo sapiens	Inhibition	%	-3.85
	8115720	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.16	CHEMBL4670	Homo sapiens	Inhibition	%	2.16
	8115853	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.82	CHEMBL4670	Homo sapiens	Inhibition	%	-0.82
	8116236	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.07	CHEMBL4670	Homo sapiens	Inhibition	%	2.07
	8116439	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.98	CHEMBL4670	Homo sapiens	Inhibition	%	3.98
	8116573	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.31	CHEMBL4670	Homo sapiens	Inhibition	%	0.31
	8116797	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.68	CHEMBL4670	Homo sapiens	Inhibition	%	-0.68
	8116969	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	15.66	CHEMBL4670	Homo sapiens	Inhibition	%	15.66
	8117140	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.18	CHEMBL4670	Homo sapiens	Inhibition	%	0.18
	8117364	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.82	CHEMBL4670	Homo sapiens	Inhibition	%	0.82
	8117522	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.56	CHEMBL4670	Homo sapiens	Inhibition	%	3.56
	8117876	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-4.68	CHEMBL4670	Homo sapiens	Inhibition	%	-4.68
	8118014	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	18.49	CHEMBL4670	Homo sapiens	Inhibition	%	18.49
	8118354	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.57	CHEMBL4670	Homo sapiens	Inhibition	%	5.57
	8118526	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	8.3	CHEMBL4670	Homo sapiens	Inhibition	%	8.3
	8118750	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	22.76	CHEMBL4670	Homo sapiens	Inhibition	%	22.76
	8118886	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	10.97	CHEMBL4670	Homo sapiens	Inhibition	%	10.97
	8119157	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.1	CHEMBL4670	Homo sapiens	Inhibition	%	3.1
	8119316	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	13.91	CHEMBL4670	Homo sapiens	Inhibition	%	13.91
	8119540	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-3.81	CHEMBL4670	Homo sapiens	Inhibition	%	-3.81
	8119707	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	5.33	CHEMBL4670	Homo sapiens	Inhibition	%	5.33
	8120050	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.58	CHEMBL4670	Homo sapiens	Inhibition	%	1.58
	8120189	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.89	CHEMBL4670	Homo sapiens	Inhibition	%	2.89
	8120573	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	Inhibition	%	0.0
	8120774	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.41	CHEMBL4670	Homo sapiens	Inhibition	%	4.41
	8121126	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.45	CHEMBL4670	Homo sapiens	Inhibition	%	-1.45
	8121298	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.66	CHEMBL4670	Homo sapiens	Inhibition	%	3.66
	8121689	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.37	CHEMBL4670	Homo sapiens	Inhibition	%	0.37
	8121852	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	8.98	CHEMBL4670	Homo sapiens	Inhibition	%	8.98
	8122197	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.38	CHEMBL4670	Homo sapiens	Inhibition	%	-1.38
	8122335	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	31.27	CHEMBL4670	Homo sapiens	Inhibition	%	31.27
	8122559	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	7.84	CHEMBL4670	Homo sapiens	Inhibition	%	7.84
	8122679	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.63	CHEMBL4670	Homo sapiens	Inhibition	%	8.63
	8123070	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	28.54	CHEMBL4670	Homo sapiens	Inhibition	%	28.54
	8123212	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.71	CHEMBL4670	Homo sapiens	Inhibition	%	4.71
	8123490	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.56	CHEMBL4670	Homo sapiens	Inhibition	%	3.56
	8123864	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-2.84	CHEMBL4670	Homo sapiens	Inhibition	%	-2.84
	8124031	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.9	CHEMBL4670	Homo sapiens	Inhibition	%	-0.9
	8124374	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.8	CHEMBL4670	Homo sapiens	Inhibition	%	2.8
	8124513	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	10.78	CHEMBL4670	Homo sapiens	Inhibition	%	10.78
	8124737	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.45	CHEMBL4670	Homo sapiens	Inhibition	%	1.45
	8124902	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.37	CHEMBL4670	Homo sapiens	Inhibition	%	-0.37
	8125103	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	36.54	CHEMBL4670	Homo sapiens	Inhibition	%	36.54
	8125327	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	37.5	CHEMBL4670	Homo sapiens	Inhibition	%	37.5
	8125457	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.08	CHEMBL4670	Homo sapiens	Inhibition	%	0.08
	8125625	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.19	CHEMBL4670	Homo sapiens	Inhibition	%	3.19
	8125849	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.47	CHEMBL4670	Homo sapiens	Inhibition	%	3.47
	8126013	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.17	CHEMBL4670	Homo sapiens	Inhibition	%	-0.17
	8126177	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	12.67	CHEMBL4670	Homo sapiens	Inhibition	%	12.67
	8126401	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.61	CHEMBL4670	Homo sapiens	Inhibition	%	2.61
	8126516	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	7.55	CHEMBL4670	Homo sapiens	Inhibition	%	7.55
	8126876	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	10.43	CHEMBL4670	Homo sapiens	Inhibition	%	10.43
	8126998	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	37.46	CHEMBL4670	Homo sapiens	Inhibition	%	37.46
	8127222	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	46.24	CHEMBL4670	Homo sapiens	Inhibition	%	46.24
	8127389	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.02	CHEMBL4670	Homo sapiens	Inhibition	%	7.02
	8127531	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.41	CHEMBL4670	Homo sapiens	Inhibition	%	4.41
	8127755	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	9.11	CHEMBL4670	Homo sapiens	Inhibition	%	9.11
	8127819	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	8.12	CHEMBL4670	Homo sapiens	Inhibition	%	8.12
	8128043	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	7.79	CHEMBL4670	Homo sapiens	Inhibition	%	7.79
	8128195	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.87	CHEMBL4670	Homo sapiens	Inhibition	%	0.87
	8128362	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.07	CHEMBL4670	Homo sapiens	Inhibition	%	-2.07
	8128586	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.66	CHEMBL4670	Homo sapiens	Inhibition	%	0.66
	8128705	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.89	CHEMBL4670	Homo sapiens	Inhibition	%	2.89
	8129066	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.9	CHEMBL4670	Homo sapiens	Inhibition	%	1.9
	8129237	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.27	CHEMBL4670	Homo sapiens	Inhibition	%	-1.27
	8129650	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.24	CHEMBL4670	Homo sapiens	Inhibition	%	2.24
	8129789	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.37	CHEMBL4670	Homo sapiens	Inhibition	%	-0.37
	8130174	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.54	CHEMBL4670	Homo sapiens	Inhibition	%	3.54
	8130346	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.03	CHEMBL4670	Homo sapiens	Inhibition	%	-1.03
	8130730	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.32	CHEMBL4670	Homo sapiens	Inhibition	%	3.32
	8130846	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	11.43	CHEMBL4670	Homo sapiens	Inhibition	%	11.43
	8131209	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	29.72	CHEMBL4670	Homo sapiens	Inhibition	%	29.72
	8131553	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	23.14	CHEMBL4670	Homo sapiens	Inhibition	%	23.14
	8131720	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.04	CHEMBL4670	Homo sapiens	Inhibition	%	7.04
	8132085	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	20.66	CHEMBL4670	Homo sapiens	Inhibition	%	20.66
	8132371	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.56	CHEMBL4670	Homo sapiens	Inhibition	%	1.56
	8132518	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.23	CHEMBL4670	Homo sapiens	Inhibition	%	1.23
	8132910	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.89	CHEMBL4670	Homo sapiens	Inhibition	%	-0.89
	8133031	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.41	CHEMBL4670	Homo sapiens	Inhibition	%	7.41
	8133255	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.89	CHEMBL4670	Homo sapiens	Inhibition	%	7.89
	8133393	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.74	CHEMBL4670	Homo sapiens	Inhibition	%	1.74
	8133565	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.84	CHEMBL4670	Homo sapiens	Inhibition	%	-1.84
	8133789	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.73	CHEMBL4670	Homo sapiens	Inhibition	%	-0.73
	8133969	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.23	CHEMBL4670	Homo sapiens	Inhibition	%	3.23
	8134117	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.27	CHEMBL4670	Homo sapiens	Inhibition	%	-1.27
	8134341	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.91	CHEMBL4670	Homo sapiens	Inhibition	%	-1.91
	8134501	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	20.01	CHEMBL4670	Homo sapiens	Inhibition	%	20.01
	8134685	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.11	CHEMBL4670	Homo sapiens	Inhibition	%	-2.11
	8135069	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.19	CHEMBL4670	Homo sapiens	Inhibition	%	4.19
	8135184	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	27.57	CHEMBL4670	Homo sapiens	Inhibition	%	27.57
	8135408	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	8.97	CHEMBL4670	Homo sapiens	Inhibition	%	8.97
	8135549	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	30.91	CHEMBL4670	Homo sapiens	Inhibition	%	30.91
	8135894	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	36.0	CHEMBL4670	Homo sapiens	Inhibition	%	36.0
	8136062	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.37	CHEMBL4670	Homo sapiens	Inhibition	%	2.37
	8136286	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.33	CHEMBL4670	Homo sapiens	Inhibition	%	2.33
	8136430	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	29.65	CHEMBL4670	Homo sapiens	Inhibition	%	29.65
	8136720	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.17	CHEMBL4670	Homo sapiens	Inhibition	%	0.17
	8136855	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.5	CHEMBL4670	Homo sapiens	Inhibition	%	2.5
	8137079	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.83	CHEMBL4670	Homo sapiens	Inhibition	%	1.83
	8137242	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-5.26	CHEMBL4670	Homo sapiens	Inhibition	%	-5.26
	8137586	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.6	CHEMBL4670	Homo sapiens	Inhibition	%	0.6
	8137734	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.62	CHEMBL4670	Homo sapiens	Inhibition	%	0.62
	8138124	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.26	CHEMBL4670	Homo sapiens	Inhibition	%	-1.26
	8138303	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.23	CHEMBL4670	Homo sapiens	Inhibition	%	2.23
	8138675	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.42	CHEMBL4670	Homo sapiens	Inhibition	%	0.42
	8138833	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	30.93	CHEMBL4670	Homo sapiens	Inhibition	%	30.93
	8139018	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.88	CHEMBL4670	Homo sapiens	Inhibition	%	-2.88
	8139242	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.77	CHEMBL4670	Homo sapiens	Inhibition	%	2.77
	8139401	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.94	CHEMBL4670	Homo sapiens	Inhibition	%	6.94
	8139739	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	10.69	CHEMBL4670	Homo sapiens	Inhibition	%	10.69
	8139880	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.01	CHEMBL4670	Homo sapiens	Inhibition	%	7.01
	8140104	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.37	CHEMBL4670	Homo sapiens	Inhibition	%	7.37
	8140227	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	13.28	CHEMBL4670	Homo sapiens	Inhibition	%	13.28
	8140610	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	7.55	CHEMBL4670	Homo sapiens	Inhibition	%	7.55
	8140753	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	31.17	CHEMBL4670	Homo sapiens	Inhibition	%	31.17
	8141055	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.99	CHEMBL4670	Homo sapiens	Inhibition	%	1.99
	8141409	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.07	CHEMBL4670	Homo sapiens	Inhibition	%	7.07
	8141569	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-4.82	CHEMBL4670	Homo sapiens	Inhibition	%	-4.82
	8141912	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.25	CHEMBL4670	Homo sapiens	Inhibition	%	0.25
	8142073	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	30.86	CHEMBL4670	Homo sapiens	Inhibition	%	30.86
	8142297	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	36.99	CHEMBL4670	Homo sapiens	Inhibition	%	36.99
	8142465	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.96	CHEMBL4670	Homo sapiens	Inhibition	%	-0.96
	8142641	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.67	CHEMBL4670	Homo sapiens	Inhibition	%	2.67
	8143014	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	9.15	CHEMBL4670	Homo sapiens	Inhibition	%	9.15
	8143169	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.18	CHEMBL4670	Homo sapiens	Inhibition	%	4.18
	8143393	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.4	CHEMBL4670	Homo sapiens	Inhibition	%	4.4
	8143580	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.75	CHEMBL4670	Homo sapiens	Inhibition	%	3.75
	8143739	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	15.61	CHEMBL4670	Homo sapiens	Inhibition	%	15.61
	8144077	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.07	CHEMBL4670	Homo sapiens	Inhibition	%	3.07
	8144440	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	33.81	CHEMBL4670	Homo sapiens	Inhibition	%	33.81
	8144570	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	31.43	CHEMBL4670	Homo sapiens	Inhibition	%	31.43
	8144947	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	9.54	CHEMBL4670	Homo sapiens	Inhibition	%	9.54
	8145084	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.71	CHEMBL4670	Homo sapiens	Inhibition	%	7.71
	8145308	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.76	CHEMBL4670	Homo sapiens	Inhibition	%	7.76
	8145397	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.18	CHEMBL4670	Homo sapiens	Inhibition	%	0.18
	8145745	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.18	CHEMBL4670	Homo sapiens	Inhibition	%	7.18
	8145906	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.42	CHEMBL4670	Homo sapiens	Inhibition	%	0.42
	8146130	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.31	CHEMBL4670	Homo sapiens	Inhibition	%	0.31
	8146250	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	4.28	CHEMBL4670	Homo sapiens	Inhibition	%	4.28
	8146634	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	6.83	CHEMBL4670	Homo sapiens	Inhibition	%	6.83
	8146801	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.6	CHEMBL4670	Homo sapiens	Inhibition	%	-1.6
	8146970	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.82	CHEMBL4670	Homo sapiens	Inhibition	%	0.82
	8147194	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.9	CHEMBL4670	Homo sapiens	Inhibition	%	1.9
	8147336	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.72	CHEMBL4670	Homo sapiens	Inhibition	%	3.72
	8147713	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	7.94	CHEMBL4670	Homo sapiens	Inhibition	%	7.94
	8147900	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.04	CHEMBL4670	Homo sapiens	Inhibition	%	8.04
	8148058	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	27.22	CHEMBL4670	Homo sapiens	Inhibition	%	27.22
	8148282	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.43	CHEMBL4670	Homo sapiens	Inhibition	%	4.43
	8148396	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.03	CHEMBL4670	Homo sapiens	Inhibition	%	2.03
	8148759	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	36.21	CHEMBL4670	Homo sapiens	Inhibition	%	36.21
	8148897	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	17.58	CHEMBL4670	Homo sapiens	Inhibition	%	17.58
	8149121	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	30.83	CHEMBL4670	Homo sapiens	Inhibition	%	30.83
	8149280	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.54	CHEMBL4670	Homo sapiens	Inhibition	%	0.54
	8149638	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.52	CHEMBL4670	Homo sapiens	Inhibition	%	3.52
	8149736	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-3.36	CHEMBL4670	Homo sapiens	Inhibition	%	-3.36
	8149960	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-4.16	CHEMBL4670	Homo sapiens	Inhibition	%	-4.16
	8150085	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.85	CHEMBL4670	Homo sapiens	Inhibition	%	2.85
	8150469	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.88	CHEMBL4670	Homo sapiens	Inhibition	%	1.88
	8150589	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	12.56	CHEMBL4670	Homo sapiens	Inhibition	%	12.56
	8150978	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	6.01	CHEMBL4670	Homo sapiens	Inhibition	%	6.01
	8151141	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	3.22	CHEMBL4670	Homo sapiens	Inhibition	%	3.22
	8151542	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.73	CHEMBL4670	Homo sapiens	Inhibition	%	1.73
	8151680	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.87	CHEMBL4670	Homo sapiens	Inhibition	%	2.87
	8152058	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	23.88	CHEMBL4670	Homo sapiens	Inhibition	%	23.88
	8152246	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	10.48	CHEMBL4670	Homo sapiens	Inhibition	%	10.48
	8152628	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.91	CHEMBL4670	Homo sapiens	Inhibition	%	5.91
	8152742	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.91	CHEMBL4670	Homo sapiens	Inhibition	%	3.91
	8152966	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.4	CHEMBL4670	Homo sapiens	Inhibition	%	6.4
	8153105	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	10.57	CHEMBL4670	Homo sapiens	Inhibition	%	10.57
	8153466	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.65	CHEMBL4670	Homo sapiens	Inhibition	%	6.65
	8153623	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.02	CHEMBL4670	Homo sapiens	Inhibition	%	-0.02
	8153980	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.94	CHEMBL4670	Homo sapiens	Inhibition	%	3.94
	8154301	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.15	CHEMBL4670	Homo sapiens	Inhibition	%	3.15
	8154427	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	16.34	CHEMBL4670	Homo sapiens	Inhibition	%	16.34
	8154810	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.66	CHEMBL4670	Homo sapiens	Inhibition	%	1.66
	8154930	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	22.35	CHEMBL4670	Homo sapiens	Inhibition	%	22.35
	8155154	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	26.85	CHEMBL4670	Homo sapiens	Inhibition	%	26.85
	8155330	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.47	CHEMBL4670	Homo sapiens	Inhibition	%	5.47
	8155491	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	18.71	CHEMBL4670	Homo sapiens	Inhibition	%	18.71
	8155715	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.25	CHEMBL4670	Homo sapiens	Inhibition	%	3.25
	8155893	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.3	CHEMBL4670	Homo sapiens	Inhibition	%	2.3
	8156031	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.73	CHEMBL4670	Homo sapiens	Inhibition	%	2.73
	8156255	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.86	CHEMBL4670	Homo sapiens	Inhibition	%	1.86
	8156467	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.67	CHEMBL4670	Homo sapiens	Inhibition	%	2.67
	8156617	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.61	CHEMBL4670	Homo sapiens	Inhibition	%	3.61
	8156841	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.92	CHEMBL4670	Homo sapiens	Inhibition	%	2.92
	8156984	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.39	CHEMBL4670	Homo sapiens	Inhibition	%	2.39
	8157328	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.08	CHEMBL4670	Homo sapiens	Inhibition	%	3.08
	8157469	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.68	CHEMBL4670	Homo sapiens	Inhibition	%	4.68
	8157823	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-1.88	CHEMBL4670	Homo sapiens	Inhibition	%	-1.88
	8157984	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	7.43	CHEMBL4670	Homo sapiens	Inhibition	%	7.43
	8158208	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	3.34	CHEMBL4670	Homo sapiens	Inhibition	%	3.34
	8158234	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.63	CHEMBL4670	Homo sapiens	Inhibition	%	1.63
	8158458	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.01	CHEMBL4670	Homo sapiens	Inhibition	%	3.01
	8158616	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	30.24	CHEMBL4670	Homo sapiens	Inhibition	%	30.24
	8158785	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.84	CHEMBL4670	Homo sapiens	Inhibition	%	3.84
	8159009	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.99	CHEMBL4670	Homo sapiens	Inhibition	%	3.99
	8159144	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.64	CHEMBL4670	Homo sapiens	Inhibition	%	-0.64
	8159488	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.43	CHEMBL4670	Homo sapiens	Inhibition	%	1.43
	8159619	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.03	CHEMBL4670	Homo sapiens	Inhibition	%	4.03
	8159843	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.62	CHEMBL4670	Homo sapiens	Inhibition	%	8.62
	8159984	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.33	CHEMBL4670	Homo sapiens	Inhibition	%	3.33
	8160345	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.44	CHEMBL4670	Homo sapiens	Inhibition	%	5.44
	8160495	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	30.01	CHEMBL4670	Homo sapiens	Inhibition	%	30.01
	8160789	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.29	CHEMBL4670	Homo sapiens	Inhibition	%	2.29
	8161163	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.83	CHEMBL4670	Homo sapiens	Inhibition	%	3.83
	8161306	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.74	CHEMBL4670	Homo sapiens	Inhibition	%	3.74
	8161655	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.45	CHEMBL4670	Homo sapiens	Inhibition	%	1.45
	8161793	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.16	CHEMBL4670	Homo sapiens	Inhibition	%	5.16
	8162017	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.87	CHEMBL4670	Homo sapiens	Inhibition	%	9.87
	8162147	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.18	CHEMBL4670	Homo sapiens	Inhibition	%	0.18
	8162531	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	18.3	CHEMBL4670	Homo sapiens	Inhibition	%	18.3
	8162784	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.01	CHEMBL4670	Homo sapiens	Inhibition	%	4.01
	8162932	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.09	CHEMBL4670	Homo sapiens	Inhibition	%	5.09
	8163325	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	8.24	CHEMBL4670	Homo sapiens	Inhibition	%	8.24
	8163459	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.5	CHEMBL4670	Homo sapiens	Inhibition	%	-0.5
	8163683	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.6	CHEMBL4670	Homo sapiens	Inhibition	%	4.6
	8163806	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.3	CHEMBL4670	Homo sapiens	Inhibition	%	1.3
	8164164	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	17.33	CHEMBL4670	Homo sapiens	Inhibition	%	17.33
	8164304	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	21.41	CHEMBL4670	Homo sapiens	Inhibition	%	21.41
	8164683	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.17	CHEMBL4670	Homo sapiens	Inhibition	%	2.17
	8164827	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	36.42	CHEMBL4670	Homo sapiens	Inhibition	%	36.42
	8165051	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.27	CHEMBL4670	Homo sapiens	Inhibition	%	3.27
	8165121	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.6	CHEMBL4670	Homo sapiens	Inhibition	%	3.6
	8165486	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.73	CHEMBL4670	Homo sapiens	Inhibition	%	1.73
	8165629	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.81	CHEMBL4670	Homo sapiens	Inhibition	%	3.81
	8165853	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.58	CHEMBL4670	Homo sapiens	Inhibition	%	2.58
	8165979	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.77	CHEMBL4670	Homo sapiens	Inhibition	%	1.77
	8166341	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.68	CHEMBL4670	Homo sapiens	Inhibition	%	9.68
	8166471	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	11.71	CHEMBL4670	Homo sapiens	Inhibition	%	11.71
	8166796	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.36	CHEMBL4670	Homo sapiens	Inhibition	%	1.36
	8167108	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.45	CHEMBL4670	Homo sapiens	Inhibition	%	3.45
	8167249	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.58	CHEMBL4670	Homo sapiens	Inhibition	%	5.58
	8167473	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-0.72	CHEMBL4670	Homo sapiens	Inhibition	%	-0.72
	8167637	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	8.43	CHEMBL4670	Homo sapiens	Inhibition	%	8.43
	8167994	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.57	CHEMBL4670	Homo sapiens	Inhibition	%	5.57
	8168118	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.46	CHEMBL4670	Homo sapiens	Inhibition	%	1.46
	8168483	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	39.69	CHEMBL4670	Homo sapiens	Inhibition	%	39.69
	8168619	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	26.38	CHEMBL4670	Homo sapiens	Inhibition	%	26.38
	8168843	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.07	CHEMBL4670	Homo sapiens	Inhibition	%	2.07
	8169007	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.0	CHEMBL4670	Homo sapiens	Inhibition	%	5.0
	8169373	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.44	CHEMBL4670	Homo sapiens	Inhibition	%	3.44
	8169453	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.72	CHEMBL4670	Homo sapiens	Inhibition	%	2.72
	8169677	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.95	CHEMBL4670	Homo sapiens	Inhibition	%	3.95
	8169811	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.25	CHEMBL4670	Homo sapiens	Inhibition	%	4.25
	8170180	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	4.92	CHEMBL4670	Homo sapiens	Inhibition	%	4.92
	8170305	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.44	CHEMBL4670	Homo sapiens	Inhibition	%	2.44
	8170529	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.04	CHEMBL4670	Homo sapiens	Inhibition	%	2.04
	8170669	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.86	CHEMBL4670	Homo sapiens	Inhibition	%	2.86
	8170804	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	25.37	CHEMBL4670	Homo sapiens	Inhibition	%	25.37
	8171028	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.55	CHEMBL4670	Homo sapiens	Inhibition	%	3.55
	8171225	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.05	CHEMBL4670	Homo sapiens	Inhibition	%	1.05
	8171442	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.54	CHEMBL4670	Homo sapiens	Inhibition	%	3.54
	8171807	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-0.02	CHEMBL4670	Homo sapiens	Inhibition	%	-0.02
	8171960	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.02	CHEMBL4670	Homo sapiens	Inhibition	%	1.02
	8172316	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.76	CHEMBL4670	Homo sapiens	Inhibition	%	6.76
	8172444	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.05	CHEMBL4670	Homo sapiens	Inhibition	%	1.05
	8172668	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-3.24	CHEMBL4670	Homo sapiens	Inhibition	%	-3.24
	8172810	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	43.4	CHEMBL4670	Homo sapiens	Inhibition	%	43.4
	8173170	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.74	CHEMBL4670	Homo sapiens	Inhibition	%	2.74
	8173335	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.62	CHEMBL4670	Homo sapiens	Inhibition	%	3.62
	8173700	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.4	CHEMBL4670	Homo sapiens	Inhibition	%	2.4
	8174011	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.57	CHEMBL4670	Homo sapiens	Inhibition	%	3.57
	8174143	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.97	CHEMBL4670	Homo sapiens	Inhibition	%	2.97
	8174515	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.0	CHEMBL4670	Homo sapiens	Inhibition	%	2.0
	8174861	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.87	CHEMBL4670	Homo sapiens	Inhibition	%	2.87
	8175004	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.31	CHEMBL4670	Homo sapiens	Inhibition	%	1.31
	8175364	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.14	CHEMBL4670	Homo sapiens	Inhibition	%	6.14
	8175620	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.15	CHEMBL4670	Homo sapiens	Inhibition	%	3.15
	8175783	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	8.73	CHEMBL4670	Homo sapiens	Inhibition	%	8.73
	8176007	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	10.96	CHEMBL4670	Homo sapiens	Inhibition	%	10.96
	8176160	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.33	CHEMBL4670	Homo sapiens	Inhibition	%	4.33
	8176309	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.04	CHEMBL4670	Homo sapiens	Inhibition	%	0.04
	8176533	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.95	CHEMBL4670	Homo sapiens	Inhibition	%	0.95
	8176665	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.08	CHEMBL4670	Homo sapiens	Inhibition	%	8.08
	8177019	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.97	CHEMBL4670	Homo sapiens	Inhibition	%	4.97
	8177161	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	6.11	CHEMBL4670	Homo sapiens	Inhibition	%	6.11
	8177385	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.25	CHEMBL4670	Homo sapiens	Inhibition	%	4.25
	8177523	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.01	CHEMBL4670	Homo sapiens	Inhibition	%	5.01
	8177687	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.56	CHEMBL4670	Homo sapiens	Inhibition	%	4.56
	8177911	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.3	CHEMBL4670	Homo sapiens	Inhibition	%	11.3
	8178051	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.92	CHEMBL4670	Homo sapiens	Inhibition	%	2.92
	8178363	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.84	CHEMBL4670	Homo sapiens	Inhibition	%	2.84
	8178490	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.34	CHEMBL4670	Homo sapiens	Inhibition	%	3.34
	8178714	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.14	CHEMBL4670	Homo sapiens	Inhibition	%	3.14
	8178863	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.94	CHEMBL4670	Homo sapiens	Inhibition	%	3.94
	8179210	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.32	CHEMBL4670	Homo sapiens	Inhibition	%	2.32
	8179354	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.05	CHEMBL4670	Homo sapiens	Inhibition	%	4.05
	8179578	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.16	CHEMBL4670	Homo sapiens	Inhibition	%	2.16
	8179715	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.91	CHEMBL4670	Homo sapiens	Inhibition	%	7.91
	8179972	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-1.34	CHEMBL4670	Homo sapiens	Inhibition	%	-1.34
	8180350	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.31	CHEMBL4670	Homo sapiens	Inhibition	%	0.31
	8180506	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.65	CHEMBL4670	Homo sapiens	Inhibition	%	4.65
	8180878	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-0.05	CHEMBL4670	Homo sapiens	Inhibition	%	-0.05
	8181011	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	14.18	CHEMBL4670	Homo sapiens	Inhibition	%	14.18
	8181366	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.79	CHEMBL4670	Homo sapiens	Inhibition	%	-0.79
	8181730	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.91	CHEMBL4670	Homo sapiens	Inhibition	%	5.91
	8181869	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	6.04	CHEMBL4670	Homo sapiens	Inhibition	%	6.04
	8182256	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	24.56	CHEMBL4670	Homo sapiens	Inhibition	%	24.56
	8182396	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.82	CHEMBL4670	Homo sapiens	Inhibition	%	1.82
	8182712	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.58	CHEMBL4670	Homo sapiens	Inhibition	%	2.58
	8183058	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.2	CHEMBL4670	Homo sapiens	Inhibition	%	3.2
	8183207	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.43	CHEMBL4670	Homo sapiens	Inhibition	%	1.43
	8183431	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.53	CHEMBL4670	Homo sapiens	Inhibition	%	3.53
	8183560	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	10.3	CHEMBL4670	Homo sapiens	Inhibition	%	10.3
	8183926	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-2.03	CHEMBL4670	Homo sapiens	Inhibition	%	-2.03
	8184062	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.63	CHEMBL4670	Homo sapiens	Inhibition	%	7.63
	8184328	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-1.95	CHEMBL4670	Homo sapiens	Inhibition	%	-1.95
	8184699	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.26	CHEMBL4670	Homo sapiens	Inhibition	%	-0.26
	8184856	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	34.39	CHEMBL4670	Homo sapiens	Inhibition	%	34.39
	8185080	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	37.76	CHEMBL4670	Homo sapiens	Inhibition	%	37.76
	8185229	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-4.92	CHEMBL4670	Homo sapiens	Inhibition	%	-4.92
	8185360	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	24.19	CHEMBL4670	Homo sapiens	Inhibition	%	24.19
	8185584	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.84	CHEMBL4670	Homo sapiens	Inhibition	%	4.84
	8185715	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.11	CHEMBL4670	Homo sapiens	Inhibition	%	-0.11
	8186078	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.31	CHEMBL4670	Homo sapiens	Inhibition	%	4.31
	8186219	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	16.83	CHEMBL4670	Homo sapiens	Inhibition	%	16.83
	8186443	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	32.48	CHEMBL4670	Homo sapiens	Inhibition	%	32.48
	8186607	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.85	CHEMBL4670	Homo sapiens	Inhibition	%	4.85
	8186746	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.65	CHEMBL4670	Homo sapiens	Inhibition	%	4.65
	8186970	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.22	CHEMBL4670	Homo sapiens	Inhibition	%	2.22
	8187068	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.57	CHEMBL4670	Homo sapiens	Inhibition	%	1.57
	8187292	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.76	CHEMBL4670	Homo sapiens	Inhibition	%	1.76
	8187416	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.5	CHEMBL4670	Homo sapiens	Inhibition	%	4.5
	8187788	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.47	CHEMBL4670	Homo sapiens	Inhibition	%	4.47
	8187917	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	30.58	CHEMBL4670	Homo sapiens	Inhibition	%	30.58
	8188284	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-2.76	CHEMBL4670	Homo sapiens	Inhibition	%	-2.76
	8188419	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.21	CHEMBL4670	Homo sapiens	Inhibition	%	-0.21
	8188643	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-1.31	CHEMBL4670	Homo sapiens	Inhibition	%	-1.31
	8188693	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.26	CHEMBL4670	Homo sapiens	Inhibition	%	4.26
	8188917	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.01	CHEMBL4670	Homo sapiens	Inhibition	%	4.01
	8189065	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.97	CHEMBL4670	Homo sapiens	Inhibition	%	0.97
	8189445	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	11.28	CHEMBL4670	Homo sapiens	Inhibition	%	11.28
	8189594	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-5.42	CHEMBL4670	Homo sapiens	Inhibition	%	-5.42
	8189950	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.44	CHEMBL4670	Homo sapiens	Inhibition	%	4.44
	8190082	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.31	CHEMBL4670	Homo sapiens	Inhibition	%	5.31
	8190306	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.33	CHEMBL4670	Homo sapiens	Inhibition	%	6.33
	8190446	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.32	CHEMBL4670	Homo sapiens	Inhibition	%	1.32
	8190807	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	27.65	CHEMBL4670	Homo sapiens	Inhibition	%	27.65
	8190971	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.21	CHEMBL4670	Homo sapiens	Inhibition	%	5.21
	8191333	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.99	CHEMBL4670	Homo sapiens	Inhibition	%	2.99
	8191653	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.46	CHEMBL4670	Homo sapiens	Inhibition	%	1.46
	8191775	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.2	CHEMBL4670	Homo sapiens	Inhibition	%	5.2
	8192148	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.44	CHEMBL4670	Homo sapiens	Inhibition	%	3.44
	8192277	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	14.54	CHEMBL4670	Homo sapiens	Inhibition	%	14.54
	8192501	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	29.27	CHEMBL4670	Homo sapiens	Inhibition	%	29.27
	8192645	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.43	CHEMBL4670	Homo sapiens	Inhibition	%	3.43
	8193005	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.28	CHEMBL4670	Homo sapiens	Inhibition	%	0.28
	8193277	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.03	CHEMBL4670	Homo sapiens	Inhibition	%	4.03
	8193422	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.08	CHEMBL4670	Homo sapiens	Inhibition	%	0.08
	8193803	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	12.14	CHEMBL4670	Homo sapiens	Inhibition	%	12.14
	8193952	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.94	CHEMBL4670	Homo sapiens	Inhibition	%	-0.94
	8194176	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.73	CHEMBL4670	Homo sapiens	Inhibition	%	-1.73
	8194307	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.93	CHEMBL4670	Homo sapiens	Inhibition	%	5.93
	8194662	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	10.45	CHEMBL4670	Homo sapiens	Inhibition	%	10.45
	8194805	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-0.36	CHEMBL4670	Homo sapiens	Inhibition	%	-0.36
	8195162	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	37.24	CHEMBL4670	Homo sapiens	Inhibition	%	37.24
	8195326	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.31	CHEMBL4670	Homo sapiens	Inhibition	%	3.31
	8195550	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.14	CHEMBL4670	Homo sapiens	Inhibition	%	2.14
	8195689	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.91	CHEMBL4670	Homo sapiens	Inhibition	%	3.91
	8196011	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.59	CHEMBL4670	Homo sapiens	Inhibition	%	3.59
	8196128	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.82	CHEMBL4670	Homo sapiens	Inhibition	%	3.82
	8196352	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.05	CHEMBL4670	Homo sapiens	Inhibition	%	4.05
	8196502	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	32.5	CHEMBL4670	Homo sapiens	Inhibition	%	32.5
	8196854	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.75	CHEMBL4670	Homo sapiens	Inhibition	%	1.75
	8196995	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.22	CHEMBL4670	Homo sapiens	Inhibition	%	3.22
	8197356	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-1.31	CHEMBL4670	Homo sapiens	Inhibition	%	-1.31
	8197631	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.82	CHEMBL4670	Homo sapiens	Inhibition	%	5.82
	8197771	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-5.38	CHEMBL4670	Homo sapiens	Inhibition	%	-5.38
	8197995	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-2.78	CHEMBL4670	Homo sapiens	Inhibition	%	-2.78
	8198152	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	8.6	CHEMBL4670	Homo sapiens	Inhibition	%	8.6
	8198514	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.67	CHEMBL4670	Homo sapiens	Inhibition	%	7.67
	8198644	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	7.13	CHEMBL4670	Homo sapiens	Inhibition	%	7.13
	8198999	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	10.26	CHEMBL4670	Homo sapiens	Inhibition	%	10.26
	8199147	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.79	CHEMBL4670	Homo sapiens	Inhibition	%	4.79
	8199371	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.13	CHEMBL4670	Homo sapiens	Inhibition	%	4.13
	8199505	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.72	CHEMBL4670	Homo sapiens	Inhibition	%	4.72
	8199892	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.97	CHEMBL4670	Homo sapiens	Inhibition	%	1.97
	8200030	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.87	CHEMBL4670	Homo sapiens	Inhibition	%	6.87
	8200358	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	22.38	CHEMBL4670	Homo sapiens	Inhibition	%	22.38
	8200697	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.87	CHEMBL4670	Homo sapiens	Inhibition	%	2.87
	8200847	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	35.99	CHEMBL4670	Homo sapiens	Inhibition	%	35.99
	8201201	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.97	CHEMBL4670	Homo sapiens	Inhibition	%	2.97
	8201336	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.12	CHEMBL4670	Homo sapiens	Inhibition	%	5.12
	8201560	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	6.72	CHEMBL4670	Homo sapiens	Inhibition	%	6.72
	8201693	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-6.68	CHEMBL4670	Homo sapiens	Inhibition	%	-6.68
	8201972	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	10.03	CHEMBL4670	Homo sapiens	Inhibition	%	10.03
	8202336	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.77	CHEMBL4670	Homo sapiens	Inhibition	%	-1.77
	8202503	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	19.82	CHEMBL4670	Homo sapiens	Inhibition	%	19.82
	8202852	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	18.37	CHEMBL4670	Homo sapiens	Inhibition	%	18.37
	8202982	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.14	CHEMBL4670	Homo sapiens	Inhibition	%	0.14
	8203206	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-0.05	CHEMBL4670	Homo sapiens	Inhibition	%	-0.05
	8203337	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.68	CHEMBL4670	Homo sapiens	Inhibition	%	3.68
	8203707	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.59	CHEMBL4670	Homo sapiens	Inhibition	%	4.59
	8203841	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.08	CHEMBL4670	Homo sapiens	Inhibition	%	6.08
	8204065	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.42	CHEMBL4670	Homo sapiens	Inhibition	%	6.42
	8204231	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.47	CHEMBL4670	Homo sapiens	Inhibition	%	2.47
	8204368	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	7.63	CHEMBL4670	Homo sapiens	Inhibition	%	7.63
	8204592	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	19.36	CHEMBL4670	Homo sapiens	Inhibition	%	19.36
	8204697	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	32.06	CHEMBL4670	Homo sapiens	Inhibition	%	32.06
	8205036	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.0	CHEMBL4670	Homo sapiens	Inhibition	%	4.0
	8205185	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.27	CHEMBL4670	Homo sapiens	Inhibition	%	5.27
	8205409	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.31	CHEMBL4670	Homo sapiens	Inhibition	%	6.31
	8205545	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.14	CHEMBL4670	Homo sapiens	Inhibition	%	3.14
	8205908	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	18.37	CHEMBL4670	Homo sapiens	Inhibition	%	18.37
	8206040	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-5.38	CHEMBL4670	Homo sapiens	Inhibition	%	-5.38
	8206264	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.21	CHEMBL4670	Homo sapiens	Inhibition	%	-2.21
	8206316	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	11.18	CHEMBL4670	Homo sapiens	Inhibition	%	11.18
	8206540	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.02	CHEMBL4670	Homo sapiens	Inhibition	%	5.02
	8206683	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.51	CHEMBL4670	Homo sapiens	Inhibition	%	-1.51
	8206863	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.24	CHEMBL4670	Homo sapiens	Inhibition	%	4.24
	8207087	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.17	CHEMBL4670	Homo sapiens	Inhibition	%	4.17
	8207213	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	13.6	CHEMBL4670	Homo sapiens	Inhibition	%	13.6
	8207567	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.49	CHEMBL4670	Homo sapiens	Inhibition	%	4.49
	8207699	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.05	CHEMBL4670	Homo sapiens	Inhibition	%	4.05
	8207923	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.06	CHEMBL4670	Homo sapiens	Inhibition	%	4.06
	8208068	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.86	CHEMBL4670	Homo sapiens	Inhibition	%	4.86
	8208424	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	13.98	CHEMBL4670	Homo sapiens	Inhibition	%	13.98
	8208590	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.74	CHEMBL4670	Homo sapiens	Inhibition	%	0.74
	8208947	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.15	CHEMBL4670	Homo sapiens	Inhibition	%	5.15
	8209052	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.08	CHEMBL4670	Homo sapiens	Inhibition	%	1.08
	8209276	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.04	CHEMBL4670	Homo sapiens	Inhibition	%	1.04
	8209392	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.5	CHEMBL4670	Homo sapiens	Inhibition	%	1.5
	8209766	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.61	CHEMBL4670	Homo sapiens	Inhibition	%	2.61
	8209902	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.96	CHEMBL4670	Homo sapiens	Inhibition	%	2.96
	8210126	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-2.77	CHEMBL4670	Homo sapiens	Inhibition	%	-2.77
	8210267	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	33.55	CHEMBL4670	Homo sapiens	Inhibition	%	33.55
	8210627	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.44	CHEMBL4670	Homo sapiens	Inhibition	%	-2.44
	8210886	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	15.67	CHEMBL4670	Homo sapiens	Inhibition	%	15.67
	8211030	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.86	CHEMBL4670	Homo sapiens	Inhibition	%	4.86
	8211424	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-1.09	CHEMBL4670	Homo sapiens	Inhibition	%	-1.09
	8211547	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	23.92	CHEMBL4670	Homo sapiens	Inhibition	%	23.92
	8211900	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.6	CHEMBL4670	Homo sapiens	Inhibition	%	5.6
	8212256	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.27	CHEMBL4670	Homo sapiens	Inhibition	%	3.27
	8212397	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	9.47	CHEMBL4670	Homo sapiens	Inhibition	%	9.47
	8212754	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.72	CHEMBL4670	Homo sapiens	Inhibition	%	5.72
	8212924	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.13	CHEMBL4670	Homo sapiens	Inhibition	%	2.13
	8213277	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.05	CHEMBL4670	Homo sapiens	Inhibition	%	6.05
	8213605	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.48	CHEMBL4670	Homo sapiens	Inhibition	%	-0.48
	8213718	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.66	CHEMBL4670	Homo sapiens	Inhibition	%	3.66
	8213942	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.57	CHEMBL4670	Homo sapiens	Inhibition	%	2.57
	8214089	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.69	CHEMBL4670	Homo sapiens	Inhibition	%	2.69
	8214450	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-0.41	CHEMBL4670	Homo sapiens	Inhibition	%	-0.41
	8214584	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	3.05	CHEMBL4670	Homo sapiens	Inhibition	%	3.05
	8214960	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.91	CHEMBL4670	Homo sapiens	Inhibition	%	0.91
	8215211	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	9.94	CHEMBL4670	Homo sapiens	Inhibition	%	9.94
	8215364	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	5.46	CHEMBL4670	Homo sapiens	Inhibition	%	5.46
	8215588	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	10.65	CHEMBL4670	Homo sapiens	Inhibition	%	10.65
	8215752	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-1.03	CHEMBL4670	Homo sapiens	Inhibition	%	-1.03
	8215871	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.35	CHEMBL4670	Homo sapiens	Inhibition	%	4.35
	8216095	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.3	CHEMBL4670	Homo sapiens	Inhibition	%	4.3
	8216214	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.27	CHEMBL4670	Homo sapiens	Inhibition	%	4.27
	8216574	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-1.04	CHEMBL4670	Homo sapiens	Inhibition	%	-1.04
	8216712	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	8.99	CHEMBL4670	Homo sapiens	Inhibition	%	8.99
	8216936	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.54	CHEMBL4670	Homo sapiens	Inhibition	%	2.54
	8217070	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.73	CHEMBL4670	Homo sapiens	Inhibition	%	6.73
	8217244	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.72	CHEMBL4670	Homo sapiens	Inhibition	%	1.72
	8217468	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.73	CHEMBL4670	Homo sapiens	Inhibition	%	1.73
	8217599	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.38	CHEMBL4670	Homo sapiens	Inhibition	%	3.38
	8217924	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.0	CHEMBL4670	Homo sapiens	Inhibition	%	-1.0
	8218263	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.19	CHEMBL4670	Homo sapiens	Inhibition	%	4.19
	8218390	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.89	CHEMBL4670	Homo sapiens	Inhibition	%	1.89
	8218757	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.08	CHEMBL4670	Homo sapiens	Inhibition	%	4.08
	8218888	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	7.65	CHEMBL4670	Homo sapiens	Inhibition	%	7.65
	8219112	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.88	CHEMBL4670	Homo sapiens	Inhibition	%	4.88
	8219272	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	8.0	CHEMBL4670	Homo sapiens	Inhibition	%	8.0
	8219522	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	23.46	CHEMBL4670	Homo sapiens	Inhibition	%	23.46
	8219907	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	11.57	CHEMBL4670	Homo sapiens	Inhibition	%	11.57
	8220076	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.36	CHEMBL4670	Homo sapiens	Inhibition	%	3.36
	8220429	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.05	CHEMBL4670	Homo sapiens	Inhibition	%	5.05
	8220543	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.34	CHEMBL4670	Homo sapiens	Inhibition	%	4.34
	8220767	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.27	CHEMBL4670	Homo sapiens	Inhibition	%	9.27
	8220905	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-1.15	CHEMBL4670	Homo sapiens	Inhibition	%	-1.15
	8221265	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.43	CHEMBL4670	Homo sapiens	Inhibition	%	1.43
	8221398	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.39	CHEMBL4670	Homo sapiens	Inhibition	%	4.39
	8221787	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	29.48	CHEMBL4670	Homo sapiens	Inhibition	%	29.48
	8221918	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.59	CHEMBL4670	Homo sapiens	Inhibition	%	4.59
	8222142	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.38	CHEMBL4670	Homo sapiens	Inhibition	%	2.38
	8222240	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.0	CHEMBL4670	Homo sapiens	Inhibition	%	3.0
	8222598	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.89	CHEMBL4670	Homo sapiens	Inhibition	%	2.89
	8222716	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.06	CHEMBL4670	Homo sapiens	Inhibition	%	4.06
	8222940	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.91	CHEMBL4670	Homo sapiens	Inhibition	%	0.91
	8223084	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	16.3	CHEMBL4670	Homo sapiens	Inhibition	%	16.3
	8223437	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	16.7	CHEMBL4670	Homo sapiens	Inhibition	%	16.7
	8223598	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	6.15	CHEMBL4670	Homo sapiens	Inhibition	%	6.15
	8223848	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-1.15	CHEMBL4670	Homo sapiens	Inhibition	%	-1.15
	8224234	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	19.93	CHEMBL4670	Homo sapiens	Inhibition	%	19.93
	8224404	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.58	CHEMBL4670	Homo sapiens	Inhibition	%	3.58
	8224763	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.91	CHEMBL4670	Homo sapiens	Inhibition	%	4.91
	8225101	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.12	CHEMBL4670	Homo sapiens	Inhibition	%	9.12
	8225235	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.03	CHEMBL4670	Homo sapiens	Inhibition	%	4.03
	8225597	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.55	CHEMBL4670	Homo sapiens	Inhibition	%	3.55
	8225732	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.68	CHEMBL4670	Homo sapiens	Inhibition	%	4.68
	8225956	CHEMBL1961970	GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.68	CHEMBL4670	Homo sapiens	Inhibition	%	3.68
	8226114	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	34.63	CHEMBL4670	Homo sapiens	Inhibition	%	34.63
	8226463	CHEMBL1961971	GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.95	CHEMBL4670	Homo sapiens	Inhibition	%	4.95
inactive	9618401	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618402	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618403	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618404	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618405	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618406	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618407	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618408	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618409	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618410	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618411	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618412	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618413	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618414	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618415	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618416	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618417	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618418	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618419	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618420	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618421	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618422	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618423	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618424	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618425	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618426	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618427	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618428	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618429	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	630.96	CHEMBL4670	Homo sapiens	pKi		6.2
inactive	9618430	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618431	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618432	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618433	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618434	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618435	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618436	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618437	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618438	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618439	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618440	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618441	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618442	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618443	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618444	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618445	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618446	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618447	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618448	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618449	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618450	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618451	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618452	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618453	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618454	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618455	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618456	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618457	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	1258.93	CHEMBL4670	Homo sapiens	pKi		5.9
inactive	9618458	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618459	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618460	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1OC		CHEMBL1996604	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618461	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618462	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618463	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618464	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618465	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618466	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618467	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618468	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618469	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618470	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618471	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618472	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618473	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618474	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618475	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618476	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618477	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618478	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618479	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618480	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618481	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618482	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618483	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618484	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618485	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618486	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	6309.57	CHEMBL4670	Homo sapiens	pKi		5.2
inactive	9618487	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618488	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618489	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618490	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618491	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618492	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618493	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618494	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618495	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618496	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618497	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	158.49	CHEMBL4670	Homo sapiens	pKi		6.8
inactive	9618498	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618499	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618500	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618501	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618502	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618503	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618504	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618505	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(F)c(N2CCC(N)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1968103	=	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9618506	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618507	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618508	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618509	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618510	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618511	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	6309.57	CHEMBL4670	Homo sapiens	pKi		5.2
inactive	9618512	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618513	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618514	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618515	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618516	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618517	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618518	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618519	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618520	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618521	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618522	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618523	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618524	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618525	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618526	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618527	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618528	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618529	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618530	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618531	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618532	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618533	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618534	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618535	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618536	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618537	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618538	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618539	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618540	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618541	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618542	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618543	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618544	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618545	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618546	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618547	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618548	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618549	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618550	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618551	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618552	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618553	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618554	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618555	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618556	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618557	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618558	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618559	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618560	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618561	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618562	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618563	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618564	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618565	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618566	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618567	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	3981.07	CHEMBL4670	Homo sapiens	pKi		5.4
inactive	9618568	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618569	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618570	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618571	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618572	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618573	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618574	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618575	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618576	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9618577	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9618578	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	6309.57	CHEMBL4670	Homo sapiens	pKi		5.2
active	9618579	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(NC2CCC(N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL1980371	=	Ki	nM	1995.26	CHEMBL4670	Homo sapiens	pKi		5.7
active	9618580	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	2511.89	CHEMBL4670	Homo sapiens	pKi		5.6
inactive	9618581	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618582	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9618583	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622140	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622141	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622142	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1ccc(CO)cc1)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1974363	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622143	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622144	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622145	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622146	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622147	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	1584.89	CHEMBL4670	Homo sapiens	pKi		5.8
inactive	9622148	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622149	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622150	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622151	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622152	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622153	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622154	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622155	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622156	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622157	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622158	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622159	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622160	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622161	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622162	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622163	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622164	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	<	Ki	nM	3981.07	CHEMBL4670	Homo sapiens	pKi		5.4
inactive	9622165	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622166	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622167	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622168	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622169	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622170	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9622171	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622172	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622173	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622174	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nsc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL2002553	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622175	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622176	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622177	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622178	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622179	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622180	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622181	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622182	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1584.89	CHEMBL4670	Homo sapiens	pKi		5.8
inactive	9622183	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622184	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622185	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622186	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622187	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622188	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9622189	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622190	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622191	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622192	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622193	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622194	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622195	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622196	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622197	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622198	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622199	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622200	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622201	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622202	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622203	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622204	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622205	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1584.89	CHEMBL4670	Homo sapiens	pKi		5.8
inactive	9622206	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622207	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622208	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622209	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622210	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	398.11	CHEMBL4670	Homo sapiens	pKi		6.4
inactive	9622211	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622212	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622213	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622214	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622215	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622216	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622217	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622218	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622219	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622220	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622221	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622222	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622223	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622224	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622225	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622226	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622227	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622228	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622229	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622230	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622231	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622232	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622233	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622234	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622235	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622236	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622237	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622238	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622239	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622240	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622241	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622242	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622243	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622244	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622245	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622246	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622247	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1995.26	CHEMBL4670	Homo sapiens	pKi		5.7
inactive	9622248	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622249	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622250	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622251	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622252	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622253	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622254	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622255	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622256	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622257	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622258	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622259	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622260	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622261	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622262	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	1584.89	CHEMBL4670	Homo sapiens	pKi		5.8
inactive	9622263	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622264	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622265	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622266	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622267	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622268	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622269	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622270	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	158.49	CHEMBL4670	Homo sapiens	pKi		6.8
inactive	9622271	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622272	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622273	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622274	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622275	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622276	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622277	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622278	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622279	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622280	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622281	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622282	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622283	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622284	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622285	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622286	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622287	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622288	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622289	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622290	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622291	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622292	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622293	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622294	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622295	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	6309.57	CHEMBL4670	Homo sapiens	pKi		5.2
inactive	9622296	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622297	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622298	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	1584.89	CHEMBL4670	Homo sapiens	pKi		5.8
inactive	9622299	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622300	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622301	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622302	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622303	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622304	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622305	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622306	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	794.33	CHEMBL4670	Homo sapiens	pKi		6.1
inactive	9622307	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622308	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622309	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622310	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622311	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622312	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622313	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622314	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622315	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622316	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622317	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622318	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622319	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622320	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622321	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622322	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622323	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622324	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622325	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622326	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622327	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622328	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622329	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622330	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622331	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622332	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622333	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622334	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622335	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622336	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622337	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622338	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622339	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622340	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622341	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622342	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622343	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622344	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622345	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622346	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	251.19	CHEMBL4670	Homo sapiens	pKi		6.6
inactive	9622347	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622348	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	3162.28	CHEMBL4670	Homo sapiens	pKi		5.5
inactive	9622349	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622350	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622351	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622352	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622353	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622354	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622355	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622356	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622357	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622358	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622359	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	50.12	CHEMBL4670	Homo sapiens	pKi		7.3
inactive	9622360	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622361	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622362	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622363	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622364	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622365	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622366	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622367	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622368	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622369	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622370	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622371	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622372	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622373	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622374	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622375	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622376	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9622377	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9622378	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625923	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9625924	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9625925	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625926	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625927	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625928	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625929	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625930	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625931	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625932	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625933	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625934	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625935	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625936	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9625937	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9625938	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625939	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625940	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625941	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625942	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625943	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9625944	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	3162.28	CHEMBL4670	Homo sapiens	pKi		5.5
inactive	9625945	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625946	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625947	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625948	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625949	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625950	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625951	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625952	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625953	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625954	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625955	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625956	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625957	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625958	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625959	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625960	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625961	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625962	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625963	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625964	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625965	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625966	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625967	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625968	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625969	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9625970	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	=	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9625971	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625972	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625973	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625974	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625975	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625976	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625977	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625978	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625979	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625980	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625981	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625982	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625983	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625984	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625985	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625986	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625987	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625988	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625989	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625990	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625991	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625992	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625993	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625994	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625995	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625996	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625997	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9625998	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9625999	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	3162.28	CHEMBL4670	Homo sapiens	pKi		5.5
inactive	9626000	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626001	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626002	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626003	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626004	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626005	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626006	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626007	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626008	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626009	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626010	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626011	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626012	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9626013	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	5011.87	CHEMBL4670	Homo sapiens	pKi		5.3
inactive	9626014	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626015	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626016	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626017	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626018	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626019	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626020	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626021	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626022	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626023	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626024	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626025	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626026	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626027	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626028	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626029	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626030	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626031	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626032	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9626033	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	=	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626034	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626035	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626036	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626037	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626038	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626039	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626040	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626041	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626042	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626043	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626044	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626045	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626046	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626047	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626048	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9626049	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	=	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9626050	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626051	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626052	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626053	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626054	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626055	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626056	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626057	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626058	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626059	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626060	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626061	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626062	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626063	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626064	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626065	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626066	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626067	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626068	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626069	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626070	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626071	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626072	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626073	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626074	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626075	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626076	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9626077	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	5011.87	CHEMBL4670	Homo sapiens	pKi		5.3
inactive	9626078	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626079	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626080	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626081	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626082	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626083	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626084	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626085	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626086	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626087	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626088	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626089	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626090	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626091	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626092	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626093	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626094	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626095	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626096	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9626097	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	2511.89	CHEMBL4670	Homo sapiens	pKi		5.6
inactive	9626098	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626099	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626100	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626101	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626102	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626103	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626104	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626105	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626106	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626107	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626108	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626109	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626110	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626111	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626112	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626113	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626114	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626115	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626116	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626117	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626118	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626119	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626120	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626121	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626122	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626123	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626124	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626125	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626126	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(c1ccccc1CNc1nc(N)nc2[nH]ccc12)S(C)(=O)=O		CHEMBL1970006	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626127	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626128	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626129	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626130	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626131	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626132	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626133	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626134	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626135	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626136	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626137	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626138	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626139	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626140	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626141	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626142	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9626143	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	5011.87	CHEMBL4670	Homo sapiens	pKi		5.3
inactive	9626144	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626145	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626146	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626147	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626148	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626149	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626150	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626151	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626152	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626153	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626154	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626155	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626156	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626157	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626158	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626159	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9626160	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	158.49	CHEMBL4670	Homo sapiens	pKi		6.8
inactive	9626161	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9626162	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629715	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629716	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629717	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629718	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629719	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629720	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9629721	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	630.96	CHEMBL4670	Homo sapiens	pKi		6.2
inactive	9629722	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629723	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629724	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629725	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629726	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629727	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629728	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629729	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9629730	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9629731	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629732	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629733	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629734	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629735	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629736	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629737	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629738	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629739	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629740	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629741	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629742	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629743	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629744	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629745	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629746	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629747	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9629748	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	=	Ki	nM	1584.89	CHEMBL4670	Homo sapiens	pKi		5.8
active	9629749	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	7943.28	CHEMBL4670	Homo sapiens	pKi		5.1
inactive	9629750	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629751	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629752	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9629753	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	=	Ki	nM	3981.07	CHEMBL4670	Homo sapiens	pKi		5.4
inactive	9629754	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629755	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629756	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629757	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629758	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629759	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629760	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
active	9629761	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	2511.89	CHEMBL4670	Homo sapiens	pKi		5.6
inactive	9629762	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629763	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629764	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629765	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629766	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629767	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629768	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629769	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629770	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629771	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629772	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629773	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629774	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629775	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629776	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629777	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629778	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629779	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629780	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629781	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629782	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629783	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629784	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629785	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629786	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629787	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629788	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629789	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629790	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629791	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629792	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629793	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629794	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629795	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629796	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629797	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629798	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629799	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629800	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629801	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
inactive	9629802	CHEMBL1963781	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	10000.0	CHEMBL4670	Homo sapiens	pKi		5.0
	10839394	CHEMBL2014960	Inhibition of MAPKAPK3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL4670	Homo sapiens	INH	%	1.0
	10839572	CHEMBL2015150	Inhibition of MAPKAP-K3 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	100.0	CHEMBL4670	Homo sapiens	Activity	%	100.0
	10840418	CHEMBL2016282	Inhibition of MAPKAP-K3 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	94.0	CHEMBL4670	Homo sapiens	Activity	%	94.0
	12046353	CHEMBL2157280	Inhibition of MAPKAPK3 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	5.7	CHEMBL4670	Homo sapiens	INH	%	5.7
	12074645	CHEMBL2161207	Inhibition of MAPKAP-K3 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	12170788	CHEMBL2209916	Inhibition of MAPKAP-K3 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	84.0	CHEMBL4670	Homo sapiens	Activity	%	84.0
	12170919	CHEMBL2213915	Inhibition of MAPKAP-K3 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	82.0	CHEMBL4670	Homo sapiens	Activity	%	82.0
	12183852	CHEMBL2211536	Inhibition of MAPK3	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	pIC50		5.0
	12195473	CHEMBL2210053	Inhibition of recombinant MK3 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	>	Ki	nM	9200.0	CHEMBL4670	Homo sapiens	Ki	nM	9200.0
	12248917	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL4670	Homo sapiens	Residual Activity	%	107.0
	12248918	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12248919	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	90.0	CHEMBL4670	Homo sapiens	Residual Activity	%	90.0
	12248920	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	102.0	CHEMBL4670	Homo sapiens	Residual Activity	%	102.0
	12248921	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12248922	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	95.0	CHEMBL4670	Homo sapiens	Residual Activity	%	95.0
	12248923	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12248924	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12248925	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	114.0	CHEMBL4670	Homo sapiens	Residual Activity	%	114.0
	12248926	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	107.0	CHEMBL4670	Homo sapiens	Residual Activity	%	107.0
	12248927	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	104.0	CHEMBL4670	Homo sapiens	Residual Activity	%	104.0
	12248928	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	93.0	CHEMBL4670	Homo sapiens	Residual Activity	%	93.0
	12248929	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12248930	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12248931	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12248932	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12248933	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12248934	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12248935	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	71.0	CHEMBL4670	Homo sapiens	Residual Activity	%	71.0
	12248936	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12248937	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	111.0	CHEMBL4670	Homo sapiens	Residual Activity	%	111.0
	12248938	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	90.0	CHEMBL4670	Homo sapiens	Residual Activity	%	90.0
	12248939	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	93.0	CHEMBL4670	Homo sapiens	Residual Activity	%	93.0
	12248940	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	96.0	CHEMBL4670	Homo sapiens	Residual Activity	%	96.0
	12248941	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	87.0	CHEMBL4670	Homo sapiens	Residual Activity	%	87.0
	12248942	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12248943	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12248944	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	124.0	CHEMBL4670	Homo sapiens	Residual Activity	%	124.0
	12248945	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12248946	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	126.0	CHEMBL4670	Homo sapiens	Residual Activity	%	126.0
	12248947	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	109.0	CHEMBL4670	Homo sapiens	Residual Activity	%	109.0
	12248948	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12248949	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12248950	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	127.0	CHEMBL4670	Homo sapiens	Residual Activity	%	127.0
	12248951	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	125.0	CHEMBL4670	Homo sapiens	Residual Activity	%	125.0
	12248952	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL4670	Homo sapiens	Residual Activity	%	96.0
	12248953	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12248954	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12248955	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12248956	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	126.0	CHEMBL4670	Homo sapiens	Residual Activity	%	126.0
	12248957	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	115.0	CHEMBL4670	Homo sapiens	Residual Activity	%	115.0
	12248958	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	131.0	CHEMBL4670	Homo sapiens	Residual Activity	%	131.0
	12248959	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	131.0	CHEMBL4670	Homo sapiens	Residual Activity	%	131.0
	12248960	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12248961	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12248962	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12248963	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	111.0	CHEMBL4670	Homo sapiens	Residual Activity	%	111.0
	12248964	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	140.0	CHEMBL4670	Homo sapiens	Residual Activity	%	140.0
	12248965	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	105.0	CHEMBL4670	Homo sapiens	Residual Activity	%	105.0
	12248966	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	92.0	CHEMBL4670	Homo sapiens	Residual Activity	%	92.0
	12248967	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12248968	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	114.0	CHEMBL4670	Homo sapiens	Residual Activity	%	114.0
	12248969	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12248970	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12248971	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	110.0	CHEMBL4670	Homo sapiens	Residual Activity	%	110.0
	12248972	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	105.0	CHEMBL4670	Homo sapiens	Residual Activity	%	105.0
	12248973	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12248974	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12248975	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12248976	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12248977	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	92.0	CHEMBL4670	Homo sapiens	Residual Activity	%	92.0
	12248978	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	68.0	CHEMBL4670	Homo sapiens	Residual Activity	%	68.0
	12248979	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	139.0	CHEMBL4670	Homo sapiens	Residual Activity	%	139.0
	12248980	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	104.0	CHEMBL4670	Homo sapiens	Residual Activity	%	104.0
	12248981	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	105.0	CHEMBL4670	Homo sapiens	Residual Activity	%	105.0
	12248982	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12248983	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	110.0	CHEMBL4670	Homo sapiens	Residual Activity	%	110.0
	12248984	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	108.0	CHEMBL4670	Homo sapiens	Residual Activity	%	108.0
	12248985	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12248986	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	118.0	CHEMBL4670	Homo sapiens	Residual Activity	%	118.0
	12248987	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	135.0	CHEMBL4670	Homo sapiens	Residual Activity	%	135.0
	12248988	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	122.0	CHEMBL4670	Homo sapiens	Residual Activity	%	122.0
	12248989	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	137.0	CHEMBL4670	Homo sapiens	Residual Activity	%	137.0
	12248990	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12248991	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	118.0	CHEMBL4670	Homo sapiens	Residual Activity	%	118.0
	12248992	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	107.0	CHEMBL4670	Homo sapiens	Residual Activity	%	107.0
	12248993	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	95.0	CHEMBL4670	Homo sapiens	Residual Activity	%	95.0
	12248994	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	108.0	CHEMBL4670	Homo sapiens	Residual Activity	%	108.0
	12248995	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	114.0	CHEMBL4670	Homo sapiens	Residual Activity	%	114.0
	12248996	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12248997	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12248998	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12248999	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	87.0	CHEMBL4670	Homo sapiens	Residual Activity	%	87.0
	12249000	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	90.0	CHEMBL4670	Homo sapiens	Residual Activity	%	90.0
	12249001	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12249002	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12249003	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12249004	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	104.0	CHEMBL4670	Homo sapiens	Residual Activity	%	104.0
	12249005	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	115.0	CHEMBL4670	Homo sapiens	Residual Activity	%	115.0
	12249006	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12249007	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12249008	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12249009	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12249010	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	105.0	CHEMBL4670	Homo sapiens	Residual Activity	%	105.0
	12249011	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	122.0	CHEMBL4670	Homo sapiens	Residual Activity	%	122.0
	12249012	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	111.0	CHEMBL4670	Homo sapiens	Residual Activity	%	111.0
	12249013	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	113.0	CHEMBL4670	Homo sapiens	Residual Activity	%	113.0
	12249014	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12249015	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL4670	Homo sapiens	Residual Activity	%	85.0
	12249016	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12249017	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	86.0	CHEMBL4670	Homo sapiens	Residual Activity	%	86.0
	12249018	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	47.0	CHEMBL4670	Homo sapiens	Residual Activity	%	47.0
	12249019	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	122.0	CHEMBL4670	Homo sapiens	Residual Activity	%	122.0
	12249020	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	95.0	CHEMBL4670	Homo sapiens	Residual Activity	%	95.0
	12249021	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	75.0	CHEMBL4670	Homo sapiens	Residual Activity	%	75.0
	12249022	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	91.0	CHEMBL4670	Homo sapiens	Residual Activity	%	91.0
	12249023	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	80.0	CHEMBL4670	Homo sapiens	Residual Activity	%	80.0
	12249024	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	115.0	CHEMBL4670	Homo sapiens	Residual Activity	%	115.0
	12249025	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12249026	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12249027	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	105.0	CHEMBL4670	Homo sapiens	Residual Activity	%	105.0
	12249028	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12249029	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12249030	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	110.0	CHEMBL4670	Homo sapiens	Residual Activity	%	110.0
	12249031	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	111.0	CHEMBL4670	Homo sapiens	Residual Activity	%	111.0
	12251864	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12251865	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12251866	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	118.0	CHEMBL4670	Homo sapiens	Residual Activity	%	118.0
	12251867	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	123.0	CHEMBL4670	Homo sapiens	Residual Activity	%	123.0
	12251868	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	120.0	CHEMBL4670	Homo sapiens	Residual Activity	%	120.0
	12251869	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	134.0	CHEMBL4670	Homo sapiens	Residual Activity	%	134.0
	12251870	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	115.0	CHEMBL4670	Homo sapiens	Residual Activity	%	115.0
	12251871	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12251872	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	111.0	CHEMBL4670	Homo sapiens	Residual Activity	%	111.0
	12251873	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12251874	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	107.0	CHEMBL4670	Homo sapiens	Residual Activity	%	107.0
	12251875	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	124.0	CHEMBL4670	Homo sapiens	Residual Activity	%	124.0
	12251876	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	139.0	CHEMBL4670	Homo sapiens	Residual Activity	%	139.0
	12251877	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	130.0	CHEMBL4670	Homo sapiens	Residual Activity	%	130.0
	12251878	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12251879	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	110.0	CHEMBL4670	Homo sapiens	Residual Activity	%	110.0
	12251880	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	104.0	CHEMBL4670	Homo sapiens	Residual Activity	%	104.0
	12251881	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12251882	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12251883	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	126.0	CHEMBL4670	Homo sapiens	Residual Activity	%	126.0
	12251884	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	114.0	CHEMBL4670	Homo sapiens	Residual Activity	%	114.0
	12251885	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12251886	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	83.0	CHEMBL4670	Homo sapiens	Residual Activity	%	83.0
	12251887	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12251888	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	93.0	CHEMBL4670	Homo sapiens	Residual Activity	%	93.0
	12251889	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12251890	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	112.0	CHEMBL4670	Homo sapiens	Residual Activity	%	112.0
	12251891	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	123.0	CHEMBL4670	Homo sapiens	Residual Activity	%	123.0
	12251892	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12251893	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12251894	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12251895	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12251896	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12251897	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	107.0	CHEMBL4670	Homo sapiens	Residual Activity	%	107.0
	12251898	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	121.0	CHEMBL4670	Homo sapiens	Residual Activity	%	121.0
	12251899	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	113.0	CHEMBL4670	Homo sapiens	Residual Activity	%	113.0
	12251900	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	107.0	CHEMBL4670	Homo sapiens	Residual Activity	%	107.0
	12251901	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	115.0	CHEMBL4670	Homo sapiens	Residual Activity	%	115.0
	12251902	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	114.0	CHEMBL4670	Homo sapiens	Residual Activity	%	114.0
	12251903	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12251904	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12251905	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	127.0	CHEMBL4670	Homo sapiens	Residual Activity	%	127.0
	12251906	CHEMBL2219257	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	114.0	CHEMBL4670	Homo sapiens	Residual Activity	%	114.0
	12251907	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	69.0	CHEMBL4670	Homo sapiens	Residual Activity	%	69.0
	12251908	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12251909	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	91.0	CHEMBL4670	Homo sapiens	Residual Activity	%	91.0
	12251910	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	114.0	CHEMBL4670	Homo sapiens	Residual Activity	%	114.0
	12251911	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12251912	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	92.0	CHEMBL4670	Homo sapiens	Residual Activity	%	92.0
	12251913	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12251914	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	65.0	CHEMBL4670	Homo sapiens	Residual Activity	%	65.0
	12251915	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12251916	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	87.0	CHEMBL4670	Homo sapiens	Residual Activity	%	87.0
	12251917	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	96.0	CHEMBL4670	Homo sapiens	Residual Activity	%	96.0
	12251918	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12251919	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12251920	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	90.0	CHEMBL4670	Homo sapiens	Residual Activity	%	90.0
	12251921	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	72.0	CHEMBL4670	Homo sapiens	Residual Activity	%	72.0
	12251922	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	95.0	CHEMBL4670	Homo sapiens	Residual Activity	%	95.0
	12251923	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	86.0	CHEMBL4670	Homo sapiens	Residual Activity	%	86.0
	12251924	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	53.0	CHEMBL4670	Homo sapiens	Residual Activity	%	53.0
	12251925	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	79.0	CHEMBL4670	Homo sapiens	Residual Activity	%	79.0
	12251926	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12251927	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12251928	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	69.0	CHEMBL4670	Homo sapiens	Residual Activity	%	69.0
	12251929	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	83.0	CHEMBL4670	Homo sapiens	Residual Activity	%	83.0
	12251930	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12251931	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	72.0	CHEMBL4670	Homo sapiens	Residual Activity	%	72.0
	12251932	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	82.0	CHEMBL4670	Homo sapiens	Residual Activity	%	82.0
	12251933	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	77.0	CHEMBL4670	Homo sapiens	Residual Activity	%	77.0
	12251934	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12251935	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12251936	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12251937	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	125.0	CHEMBL4670	Homo sapiens	Residual Activity	%	125.0
	12251938	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	67.0	CHEMBL4670	Homo sapiens	Residual Activity	%	67.0
	12251939	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	90.0	CHEMBL4670	Homo sapiens	Residual Activity	%	90.0
	12251940	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	109.0	CHEMBL4670	Homo sapiens	Residual Activity	%	109.0
	12251941	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12251942	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12251943	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12251944	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	133.0	CHEMBL4670	Homo sapiens	Residual Activity	%	133.0
	12251945	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12251946	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12251947	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	146.0	CHEMBL4670	Homo sapiens	Residual Activity	%	146.0
	12251948	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	111.0	CHEMBL4670	Homo sapiens	Residual Activity	%	111.0
	12251949	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	77.0	CHEMBL4670	Homo sapiens	Residual Activity	%	77.0
	12251950	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	74.0	CHEMBL4670	Homo sapiens	Residual Activity	%	74.0
	12251951	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	56.0	CHEMBL4670	Homo sapiens	Residual Activity	%	56.0
	12251952	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12251953	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	115.0	CHEMBL4670	Homo sapiens	Residual Activity	%	115.0
	12251954	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12251955	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	108.0	CHEMBL4670	Homo sapiens	Residual Activity	%	108.0
	12251956	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12251957	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	135.0	CHEMBL4670	Homo sapiens	Residual Activity	%	135.0
	12251958	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12251959	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	99.0	CHEMBL4670	Homo sapiens	Residual Activity	%	99.0
	12251960	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	111.0	CHEMBL4670	Homo sapiens	Residual Activity	%	111.0
	12251961	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	110.0	CHEMBL4670	Homo sapiens	Residual Activity	%	110.0
	12251962	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	121.0	CHEMBL4670	Homo sapiens	Residual Activity	%	121.0
	12251963	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	93.0	CHEMBL4670	Homo sapiens	Residual Activity	%	93.0
	12251964	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	86.0	CHEMBL4670	Homo sapiens	Residual Activity	%	86.0
	12251965	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12251966	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12251967	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	61.0	CHEMBL4670	Homo sapiens	Residual Activity	%	61.0
	12251968	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	37.0	CHEMBL4670	Homo sapiens	Residual Activity	%	37.0
	12251969	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	109.0	CHEMBL4670	Homo sapiens	Residual Activity	%	109.0
	12251970	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL4670	Homo sapiens	Residual Activity	%	93.0
	12251971	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	118.0	CHEMBL4670	Homo sapiens	Residual Activity	%	118.0
	12251972	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12251973	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	81.0	CHEMBL4670	Homo sapiens	Residual Activity	%	81.0
	12251974	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12251975	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	91.0	CHEMBL4670	Homo sapiens	Residual Activity	%	91.0
	12251976	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	127.0	CHEMBL4670	Homo sapiens	Residual Activity	%	127.0
	12251977	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	93.0	CHEMBL4670	Homo sapiens	Residual Activity	%	93.0
	12251978	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	107.0	CHEMBL4670	Homo sapiens	Residual Activity	%	107.0
	12251979	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	109.0	CHEMBL4670	Homo sapiens	Residual Activity	%	109.0
	12251980	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	115.0	CHEMBL4670	Homo sapiens	Residual Activity	%	115.0
	12251981	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	104.0	CHEMBL4670	Homo sapiens	Residual Activity	%	104.0
	12251982	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	130.0	CHEMBL4670	Homo sapiens	Residual Activity	%	130.0
	12251983	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	81.0	CHEMBL4670	Homo sapiens	Residual Activity	%	81.0
	12251984	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12251985	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12251986	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	46.0	CHEMBL4670	Homo sapiens	Residual Activity	%	46.0
	12251987	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	78.0	CHEMBL4670	Homo sapiens	Residual Activity	%	78.0
	12251988	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	92.0	CHEMBL4670	Homo sapiens	Residual Activity	%	92.0
	12251989	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12251990	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	85.0	CHEMBL4670	Homo sapiens	Residual Activity	%	85.0
	12251991	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	92.0	CHEMBL4670	Homo sapiens	Residual Activity	%	92.0
	12251992	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	119.0	CHEMBL4670	Homo sapiens	Residual Activity	%	119.0
	12251993	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	113.0	CHEMBL4670	Homo sapiens	Residual Activity	%	113.0
	12251994	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	92.0	CHEMBL4670	Homo sapiens	Residual Activity	%	92.0
	12251995	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	79.0	CHEMBL4670	Homo sapiens	Residual Activity	%	79.0
	12251996	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12251997	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12251998	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	93.0	CHEMBL4670	Homo sapiens	Residual Activity	%	93.0
	12251999	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	91.0	CHEMBL4670	Homo sapiens	Residual Activity	%	91.0
	12252000	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	79.0	CHEMBL4670	Homo sapiens	Residual Activity	%	79.0
	12252001	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	85.0	CHEMBL4670	Homo sapiens	Residual Activity	%	85.0
	12252002	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	104.0	CHEMBL4670	Homo sapiens	Residual Activity	%	104.0
	12252003	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	76.0	CHEMBL4670	Homo sapiens	Residual Activity	%	76.0
	12252004	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	85.0	CHEMBL4670	Homo sapiens	Residual Activity	%	85.0
	12252005	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	61.0	CHEMBL4670	Homo sapiens	Residual Activity	%	61.0
	12252006	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	86.0	CHEMBL4670	Homo sapiens	Residual Activity	%	86.0
	12252007	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	82.0	CHEMBL4670	Homo sapiens	Residual Activity	%	82.0
	12252008	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL4670	Homo sapiens	Residual Activity	%	2.0
	12252009	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12252010	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	95.0	CHEMBL4670	Homo sapiens	Residual Activity	%	95.0
	12252011	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	53.0	CHEMBL4670	Homo sapiens	Residual Activity	%	53.0
	12252012	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	80.0	CHEMBL4670	Homo sapiens	Residual Activity	%	80.0
	12252013	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12252014	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12252015	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	96.0	CHEMBL4670	Homo sapiens	Residual Activity	%	96.0
	12252016	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	89.0	CHEMBL4670	Homo sapiens	Residual Activity	%	89.0
	12252017	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	104.0	CHEMBL4670	Homo sapiens	Residual Activity	%	104.0
	12252018	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	101.0	CHEMBL4670	Homo sapiens	Residual Activity	%	101.0
	12252019	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	49.0	CHEMBL4670	Homo sapiens	Residual Activity	%	49.0
	12252020	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	85.0	CHEMBL4670	Homo sapiens	Residual Activity	%	85.0
	12252021	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	127.0	CHEMBL4670	Homo sapiens	Residual Activity	%	127.0
	12252022	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	110.0	CHEMBL4670	Homo sapiens	Residual Activity	%	110.0
	12252023	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	86.0	CHEMBL4670	Homo sapiens	Residual Activity	%	86.0
	12252024	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12252025	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	102.0	CHEMBL4670	Homo sapiens	Residual Activity	%	102.0
	12252026	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12252027	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	117.0	CHEMBL4670	Homo sapiens	Residual Activity	%	117.0
	12252028	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12252029	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12252030	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	82.0	CHEMBL4670	Homo sapiens	Residual Activity	%	82.0
	12252031	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	80.0	CHEMBL4670	Homo sapiens	Residual Activity	%	80.0
	12252032	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12252033	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12252034	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	116.0	CHEMBL4670	Homo sapiens	Residual Activity	%	116.0
	12252035	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	109.0	CHEMBL4670	Homo sapiens	Residual Activity	%	109.0
	12252036	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	41.0	CHEMBL4670	Homo sapiens	Residual Activity	%	41.0
	12252037	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	98.0	CHEMBL4670	Homo sapiens	Residual Activity	%	98.0
	12252038	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	97.0	CHEMBL4670	Homo sapiens	Residual Activity	%	97.0
	12252039	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12252040	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12252041	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	112.0	CHEMBL4670	Homo sapiens	Residual Activity	%	112.0
	12252042	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12252043	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	94.0	CHEMBL4670	Homo sapiens	Residual Activity	%	94.0
	12252044	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	69.0	CHEMBL4670	Homo sapiens	Residual Activity	%	69.0
	12252045	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	91.0	CHEMBL4670	Homo sapiens	Residual Activity	%	91.0
	12252046	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	66.0	CHEMBL4670	Homo sapiens	Residual Activity	%	66.0
	12252047	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12252048	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	103.0	CHEMBL4670	Homo sapiens	Residual Activity	%	103.0
	12252049	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	106.0	CHEMBL4670	Homo sapiens	Residual Activity	%	106.0
	12252050	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	84.0	CHEMBL4670	Homo sapiens	Residual Activity	%	84.0
	12252051	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	78.0	CHEMBL4670	Homo sapiens	Residual Activity	%	78.0
	12252052	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	91.0	CHEMBL4670	Homo sapiens	Residual Activity	%	91.0
	12252053	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	90.0	CHEMBL4670	Homo sapiens	Residual Activity	%	90.0
	12252054	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	68.0	CHEMBL4670	Homo sapiens	Residual Activity	%	68.0
	12252055	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	112.0	CHEMBL4670	Homo sapiens	Residual Activity	%	112.0
	12252056	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	118.0	CHEMBL4670	Homo sapiens	Residual Activity	%	118.0
	12252057	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	123.0	CHEMBL4670	Homo sapiens	Residual Activity	%	123.0
	12252058	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	82.0	CHEMBL4670	Homo sapiens	Residual Activity	%	82.0
	12252059	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12252060	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	100.0	CHEMBL4670	Homo sapiens	Residual Activity	%	100.0
	12252061	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	88.0	CHEMBL4670	Homo sapiens	Residual Activity	%	88.0
	12252062	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	105.0	CHEMBL4670	Homo sapiens	Residual Activity	%	105.0
	12252063	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	102.0	CHEMBL4670	Homo sapiens	Residual Activity	%	102.0
	12252064	CHEMBL2219258	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	113.0	CHEMBL4670	Homo sapiens	Residual Activity	%	113.0
	12672997	CHEMBL2339724	Inhibition of recombinant MAPKAPK3 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	78.0	CHEMBL4670	Homo sapiens	Activity	%	78.0
	12672998	CHEMBL2339724	Inhibition of recombinant MAPKAPK3 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	80.0	CHEMBL4670	Homo sapiens	Activity	%	80.0
	12693214	CHEMBL2343899	Inhibition of MAPKAPK3 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	nM	10000.0
	12727739	CHEMBL2351173	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	99.0	CHEMBL4670	Homo sapiens	Activity	%	99.0
	12729027	CHEMBL2351934	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	101.0	CHEMBL4670	Homo sapiens	Activity	%	101.0
	12729912	CHEMBL2350057	Inhibition of MAPKAPK3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	99.0	CHEMBL4670	Homo sapiens	Activity	%	99.0
	12730170	CHEMBL2351173	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL4670	Homo sapiens	Activity	%	98.0
	13375787	CHEMBL2404183	Inhibition of MAPKAPK3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL4670	Homo sapiens	INH	%	1.0
	13440853	CHEMBL2429597	Inhibition of MAPKAP-K3 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-24.0	CHEMBL4670	Homo sapiens	INH	%	-24.0
	13453031	CHEMBL2429597	Inhibition of MAPKAP-K3 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156	=	Inhibition	%	-8.0	CHEMBL4670	Homo sapiens	INH	%	-8.0
	13453079	CHEMBL2429597	Inhibition of MAPKAP-K3 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-17.0	CHEMBL4670	Homo sapiens	INH	%	-17.0
Not Active	13508499	CHEMBL2447373	Inhibition of MAPKAPK3 (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL4670	Homo sapiens	INH		
	13872104	CHEMBL3101413	Inhibition of human MAPKAP-K3 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	98.0	CHEMBL4670	Homo sapiens	Activity	%	98.0
	13966039	CHEMBL3136654	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	0.5	CHEMBL4670	Homo sapiens	INH	%	0.5
	13973314	CHEMBL3135052	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	13974032	CHEMBL3136624	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	7.0	CHEMBL4670	Homo sapiens	INH	%	7.0
	13974123	CHEMBL3135769	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	74.0	CHEMBL4670	Homo sapiens	INH	%	74.0
	13974214	CHEMBL3135287	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	98.0	CHEMBL4670	Homo sapiens	INH	%	98.0
	13974952	CHEMBL3136974	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	96.5	CHEMBL4670	Homo sapiens	INH	%	96.5
	13975043	CHEMBL3136121	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	13975134	CHEMBL3135845	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	7.0	CHEMBL4670	Homo sapiens	INH	%	7.0
	13975225	CHEMBL3136383	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	45.5	CHEMBL4670	Homo sapiens	INH	%	45.5
	13975868	CHEMBL3135483	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	81.5	CHEMBL4670	Homo sapiens	INH	%	81.5
	13975961	CHEMBL3137015	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	4.0	CHEMBL4670	Homo sapiens	INH	%	4.0
	13976052	CHEMBL3136036	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	24.0	CHEMBL4670	Homo sapiens	INH	%	24.0
	13976143	CHEMBL3135080	Inhibition of human full length MAPKAPK3 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	1.5	CHEMBL4670	Homo sapiens	INH	%	1.5
	14582544	CHEMBL3242545	Inhibition of human MAPKAP-K3 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	121.0	CHEMBL4670	Homo sapiens	Activity	%	121.0
	14593766	CHEMBL3241177	Inhibition of human MAPKAPK3	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	uM	10.0
	14645924	CHEMBL3270965	Inhibition of MAPKAPK3 (unknown origin)	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1		CHEMBL3263640	=	IC50	nM	213.0	CHEMBL4670	Homo sapiens	IC50	uM	0.213
	15072464	CHEMBL3380110	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	94.0	CHEMBL4670	Homo sapiens	Activity	%	94.0
	15122471	CHEMBL3367695	Inhibition of human MAPKAP-K3 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	117.0	CHEMBL4670	Homo sapiens	Activity	%	117.0
	15126966	CHEMBL3367695	Inhibition of human MAPKAP-K3 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	122.0	CHEMBL4670	Homo sapiens	Activity	%	122.0
	15126998	CHEMBL3367695	Inhibition of human MAPKAP-K3 assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	95.0	CHEMBL4670	Homo sapiens	Activity	%	95.0
	15251796	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	43.0	CHEMBL4670	Homo sapiens	Activity	%	43.0
	15251898	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	33.0	CHEMBL4670	Homo sapiens	Activity	%	33.0
	15252001	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	79.0	CHEMBL4670	Homo sapiens	Activity	%	79.0
	15252646	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	41.0	CHEMBL4670	Homo sapiens	Activity	%	41.0
	15252748	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	18.0	CHEMBL4670	Homo sapiens	Activity	%	18.0
	15252850	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	28.0	CHEMBL4670	Homo sapiens	Activity	%	28.0
	15253524	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	50.0	CHEMBL4670	Homo sapiens	Activity	%	50.0
	15253626	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	54.0	CHEMBL4670	Homo sapiens	Activity	%	54.0
	15253728	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	45.0	CHEMBL4670	Homo sapiens	Activity	%	45.0
	15254394	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	16.0	CHEMBL4670	Homo sapiens	Activity	%	16.0
	15254496	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	62.0	CHEMBL4670	Homo sapiens	Activity	%	62.0
	15254598	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	48.0	CHEMBL4670	Homo sapiens	Activity	%	48.0
	15255289	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	8.0	CHEMBL4670	Homo sapiens	Activity	%	8.0
	15255391	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	26.0	CHEMBL4670	Homo sapiens	Activity	%	26.0
	15255494	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	77.0	CHEMBL4670	Homo sapiens	Activity	%	77.0
	15256225	CHEMBL3427804	Inhibition of MAPKAPK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	54.0	CHEMBL4670	Homo sapiens	Activity	%	54.0
	15756928	CHEMBL3631282	Inhibition of MAPKAPK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-4.91	CHEMBL4670	Homo sapiens	INH	%	-4.91
	15757795	CHEMBL3631282	Inhibition of MAPKAPK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	-3.69	CHEMBL4670	Homo sapiens	INH	%	-3.69
	15758774	CHEMBL3631282	Inhibition of MAPKAPK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	0.16	CHEMBL4670	Homo sapiens	INH	%	0.16
	16413476	CHEMBL3742704	Inhibition of MK3 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	uM	10.0
	16425346	CHEMBL3751246	Inhibition of MAPKAPK3 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	6.9	CHEMBL4670	Homo sapiens	INH	%	6.9
	16431890	CHEMBL3747983	Inhibition of human MAPKAPK3 using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	uM	10.0
	16451502	CHEMBL3760625	Inhibition of MAPKAPK3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	5.4	CHEMBL4670	Homo sapiens	INH	%	5.4
	16495123	CHEMBL3776241	Inhibition of N-terminal His6-tagged recombinant human MAPKAP-K3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-3.0	CHEMBL4670	Homo sapiens	Activity	%	-3.0
	16496042	CHEMBL3776241	Inhibition of N-terminal His6-tagged recombinant human MAPKAP-K3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-10.0	CHEMBL4670	Homo sapiens	Activity	%	-10.0
	16508229	CHEMBL3776241	Inhibition of N-terminal His6-tagged recombinant human MAPKAP-K3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-10.0	CHEMBL4670	Homo sapiens	Activity	%	-10.0
	16611973	CHEMBL3815438	Inhibition of human MAPKAPK3 (2 to 382 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-8.0	CHEMBL4670	Homo sapiens	Activity	%	-8.0
	16611974	CHEMBL3815438	Inhibition of human MAPKAPK3 (2 to 382 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	17.0	CHEMBL4670	Homo sapiens	Activity	%	17.0
	16614527	CHEMBL3816725	Inhibition of human MAPKAPK3 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-2.0	CHEMBL4670	Homo sapiens	INH	%	-2.0
	16618170	CHEMBL3817261	Inhibition of full length recombinant human His-tagged MAPKAPK3 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	16654157	CHEMBL3829166	Inhibition of human MAPKAPK3 assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	83.0	CHEMBL4670	Homo sapiens	Activity	%	83.0
Inactive	17916886	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916887	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916888	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916889	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916890	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916891	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916892	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916893	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916894	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916895	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916896	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916897	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916898	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916899	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916900	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916901	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916902	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916903	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916904	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916905	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916906	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916907	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916908	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916909	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916910	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916911	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916912	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916913	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916914	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916915	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916916	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916917	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916918	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916919	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17916920	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	2.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	2.0
Inactive	17916921	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916922	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916923	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916924	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916925	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916926	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916927	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916928	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916929	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916930	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Active	17916931	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	23.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	23.0
Inactive	17916932	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916933	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916934	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916935	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916936	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916937	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916938	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916939	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916940	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916941	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916942	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Active	17916943	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	26.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	26.0
Inactive	17916944	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916945	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916946	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916947	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916948	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916949	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916950	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916951	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916952	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916953	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916954	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916955	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916956	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916957	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916958	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916959	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916960	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916961	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916962	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916963	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916964	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916965	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916966	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916967	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916968	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916969	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916970	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916971	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916972	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916973	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916974	CHEMBL3991779	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4670	Homo sapiens	Kd apparent	nM	30000.0
	18153074	CHEMBL4034389	Inhibition of MAPKAPK3 ATP binding site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	12.2	CHEMBL4670	Homo sapiens	INH	%	12.2
	18211570	CHEMBL4045749	Inhibition of MAPKAPK3 ATP binding site (QVLGLGVNGKVLECFHR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	2.5	CHEMBL4670	Homo sapiens	INH	%	2.5
	18211894	CHEMBL4045990	Inhibition of MAPKAPK3 ATP binding site (QVLGLGVNGKVLECFHR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	9.4	CHEMBL4670	Homo sapiens	INH	%	9.4
	18225203	CHEMBL4048706	Inhibition of MAPKAPK3 (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	54.0	CHEMBL4670	Homo sapiens	INH	%	54.0
	18232165	CHEMBL4050341	Inhibition of human MAPKAP-K3 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	82.0	CHEMBL4670	Homo sapiens	Activity	%	82.0
	18265896	CHEMBL4057346	Inhibition of MAPKAPK3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	4.0	CHEMBL4670	Homo sapiens	INH	%	4.0
	18266090	CHEMBL4057540	Inhibition of MAPKAPK3 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-7.3	CHEMBL4670	Homo sapiens	INH	%	-7.3
	18282164	CHEMBL4120119	Inhibition of recombinant full length His-tagged human MAPKAPK3 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	5.7	CHEMBL4670	Homo sapiens	INH	%	5.7
	18282483	CHEMBL4120119	Inhibition of recombinant full length His-tagged human MAPKAPK3 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-1.3	CHEMBL4670	Homo sapiens	INH	%	-1.3
	18282808	CHEMBL4120393	Inhibition of MAPKAPK3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	4.0	CHEMBL4670	Homo sapiens	INH	%	4.0
	18283035	CHEMBL4120620	Inhibition of MAPKAPK3 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-1.7	CHEMBL4670	Homo sapiens	INH	%	-1.7
	18283259	CHEMBL4120844	Inhibition of MAPKAPK3 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	6.3	CHEMBL4670	Homo sapiens	INH	%	6.3
	18449894	CHEMBL4178128	Inhibition of human MAPKAPK3 (2 to 382 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	100.0	CHEMBL4670	Homo sapiens	Activity	%	100.0
	18450272	CHEMBL4178306	Inhibition of recombinant human full length N-terminal GST-tagged MAPKAPK3 expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-4.0	CHEMBL4670	Homo sapiens	Activity	%	-4.0
	18450322	CHEMBL4178306	Inhibition of recombinant human full length N-terminal GST-tagged MAPKAPK3 expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	3.0	CHEMBL4670	Homo sapiens	Activity	%	3.0
	18506040	CHEMBL4190486	Binding affinity to MAPKAPK3 (unknown origin)	B	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOc2cc3nccc(Nc4ccc5scnc5c4)c3cc2S(=O)(=O)OC(C)(C)C)C(C)(C)C)cc1		CHEMBL4205154	>	Kd	nM	3000.0	CHEMBL4670	Homo sapiens	Kd	uM	3.0
	18507722	CHEMBL4191040	Inhibition of recombinant human MAPKAPK3 (2 to end residues) at 1 uM using KKLNRTLSVA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-1.0	CHEMBL4670	Homo sapiens	INH	%	-1.0
	18653535	CHEMBL4230136	Inhibition of MAPKAPK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	13.0	CHEMBL4670	Homo sapiens	INH	%	13.0
	18653536	CHEMBL4230136	Inhibition of MAPKAPK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	3.0	CHEMBL4670	Homo sapiens	INH	%	3.0
	18665394	CHEMBL4233351	Inhibition of MAPKAPK3 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4670	Homo sapiens	IC50	nM	1000.0
	18751036	CHEMBL4263854	Inhibition of MAPKAPK3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	2.0	CHEMBL4670	Homo sapiens	INH	%	2.0
	18892645	CHEMBL4314604	Inhibition of recombinant human MAPKAPK3 (2 to end residues) assessed as residual activity at 10 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL4670	Homo sapiens	Activity	%	105.5
	18938053	CHEMBL4327753	Inhibition of human MAPKAPK3 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.58	CHEMBL4670	Homo sapiens	Activity	%	99.58
	18938054	CHEMBL4327753	Inhibition of human MAPKAPK3 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.88	CHEMBL4670	Homo sapiens	Activity	%	99.88
	18938598	CHEMBL4328117	Inhibition of human MAPKAPK3 assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4670	Homo sapiens	Activity	%	65.0
	18938978	CHEMBL4328481	Inhibition of human MAPKAPK3 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3550.0	CHEMBL4670	Homo sapiens	IC50	10'-6M	3.55
	18964429	CHEMBL4335153	Inhibition of recombinant human MAPKAPK3 (2 to end residues) assessed as residual activity at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL4670	Homo sapiens	Activity	%	97.0
	18964430	CHEMBL4335153	Inhibition of recombinant human MAPKAPK3 (2 to end residues) assessed as residual activity at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	96.0	CHEMBL4670	Homo sapiens	Activity	%	96.0
	18971970	CHEMBL4336980	Inhibition of recombinant human MAPKAPK3 (2 to end residues) assessed as residual activity at 10 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	76.0	CHEMBL4670	Homo sapiens	Activity	%	76.0
	18985704	CHEMBL4340003	Inhibition of MAPKAPK3 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	nM	10000.0
Not Active	19039711	CHEMBL4351931	Inhibition of recombinant human MAPKAPK3 (2 to end residues) at 10 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4670	Homo sapiens	INH		
Active	19041168	CHEMBL4352429	Inhibition of human MAPKAPK3 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4670	Homo sapiens	INH		
	19091990	CHEMBL4366464	Inhibition of human MAPKAPK3 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	12.77	CHEMBL4670	Homo sapiens	INH	%	12.77
	19144954	CHEMBL4377970	Inhibition of recombinant human MAPKAPK3 (2 to end residues) at 1 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	19147918	CHEMBL4379392	Inhibition of recombinant human MAPKAPK3 (2 to end residues) using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4670	Homo sapiens	IC50	uM	10.0
	19181074	CHEMBL4387285	Inhibition of recombinant full length human His-tagged MAPKAPK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	9.0	CHEMBL4670	Homo sapiens	INH	%	9.0
	19181300	CHEMBL4387285	Inhibition of recombinant full length human His-tagged MAPKAPK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	1.0	CHEMBL4670	Homo sapiens	INH	%	1.0
	19266487	CHEMBL4405437	Inhibition of MAPKAPK3 (unknown origin) at 1 uM relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4670	Homo sapiens	INH	%	50.0
	19276030	CHEMBL4408033	Inhibition of recombinant human MAPKAPK3 (2 to end residues) at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
Active	19317093	CHEMBL4417287	Inhibition of MAPKAPK3 (unknown origin) at 1000 nM relative to control	B	Cc1c(C(=O)Nc2ccc3ccccc3n2)cnn1-c1ccccc1Br		CHEMBL4555217		Inhibition	%		CHEMBL4670	Homo sapiens	INH		
	20600435	CHEMBL4603314	Inhibition of recombinant His-tagged human full length MAPKAPK3 expressed in baculovirus expression system using Ser/Thr-04 peptide as substrate after 1 hr in presence of ATP by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	23470.0	CHEMBL4670	Homo sapiens	IC50	uM	23.47
	20604095	CHEMBL4604472	Inhibition of His-tagged human MAPKAPK3 expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	Inhibition	%	100.0	CHEMBL4670	Homo sapiens	INH	%	100.0
	20604096	CHEMBL4604472	Inhibition of His-tagged human MAPKAPK3 expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	Inhibition	%	101.0	CHEMBL4670	Homo sapiens	INH	%	101.0
	20604097	CHEMBL4604472	Inhibition of His-tagged human MAPKAPK3 expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	Inhibition	%	98.0	CHEMBL4670	Homo sapiens	INH	%	98.0
	20604108	CHEMBL4604472	Inhibition of His-tagged human MAPKAPK3 expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	Inhibition	%	99.0	CHEMBL4670	Homo sapiens	INH	%	99.0
	20604109	CHEMBL4604472	Inhibition of His-tagged human MAPKAPK3 expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	Inhibition	%	98.0	CHEMBL4670	Homo sapiens	INH	%	98.0
	20604110	CHEMBL4604472	Inhibition of His-tagged human MAPKAPK3 expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	Inhibition	%	83.0	CHEMBL4670	Homo sapiens	INH	%	83.0
	20683718	CHEMBL4623655	Inhibition of human MAPKAPK3 using KKLNRTLSVA as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4635411	=	Inhibition	%	3.095	CHEMBL4670	Homo sapiens	INH	%	3.095
	22392094	CHEMBL4667189	Inhibition of recombinant human His-tagged full length MAPKAPK3 expressed in baculovirus expression system using Ser/Thr 04 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.5	CHEMBL4670	Homo sapiens	INH	%	0.5
	22423491	CHEMBL4674321	Inhibition of human MAPKAPK3 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	98.8	CHEMBL4670	Homo sapiens	Activity	%	98.8
	22423492	CHEMBL4674321	Inhibition of human MAPKAPK3 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	96.01	CHEMBL4670	Homo sapiens	Activity	%	96.01
	22766975	CHEMBL4703354	Inhibition of MAPKAPK3 (unknown origin) at 100 nM	B	C=CC(=O)Nc1cccc(C)c1Nc1cc(-c2cccnc2Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL4744686	=	Inhibition	%	-7.0	CHEMBL4670	Homo sapiens	INH	%	-7.0
	22843685	CHEMBL4720671	Inhibition of human MAPKAPK3 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2000.0	CHEMBL4670	Homo sapiens	IC50	10^-6M	2.0
	22844035	CHEMBL4721021	Inhibition of human MAPKAPK3 assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	91.14	CHEMBL4670	Homo sapiens	Activity	%	91.14
	22844779	CHEMBL4721454	Inhibition of human MAPKAPK3 assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	101.0	CHEMBL4670	Homo sapiens	Activity	%	101.0
	22952895	CHEMBL4766832	Inhibition of recombinant human MAPKAPK3 (2 to end residues) assessed as residual activity at 10 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	101.0	CHEMBL4670	Homo sapiens	Activity	%	101.0
	23120644	CHEMBL4804424	Inhibition of MAPKAPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	2500.0	CHEMBL4670	Homo sapiens	IC50	uM	2.5
	23120645	CHEMBL4804424	Inhibition of MAPKAPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-5000.0	CHEMBL4670	Homo sapiens	IC50	uM	-5.0
	23120646	CHEMBL4804424	Inhibition of MAPKAPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-29500.0	CHEMBL4670	Homo sapiens	IC50	uM	-29.5
	23120647	CHEMBL4804424	Inhibition of MAPKAPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-65200.0	CHEMBL4670	Homo sapiens	IC50	uM	-65.2
	23120648	CHEMBL4804424	Inhibition of MAPKAPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-52200.0	CHEMBL4670	Homo sapiens	IC50	uM	-52.2
	23120649	CHEMBL4804424	Inhibition of MAPKAPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	4000.0	CHEMBL4670	Homo sapiens	IC50	uM	4.0
	23121683	CHEMBL4804606	Inhibition of MAPKAPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	23121684	CHEMBL4804606	Inhibition of MAPKAPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	23121685	CHEMBL4804606	Inhibition of MAPKAPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	23121686	CHEMBL4804606	Inhibition of MAPKAPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	23121687	CHEMBL4804606	Inhibition of MAPKAPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	23121688	CHEMBL4804606	Inhibition of MAPKAPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL4670	Homo sapiens	INH	%	0.0
	23128266	CHEMBL4807897	Inhibition of MAPKAPK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4670	Homo sapiens	Activity	%	75.0
	23128267	CHEMBL4807897	Inhibition of MAPKAPK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4670	Homo sapiens	Activity	%	75.0
	23128268	CHEMBL4807897	Inhibition of MAPKAPK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4670	Homo sapiens	Activity	%	75.0
Not Active	23324052	CHEMBL4880671	MAPKAP-K3 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-5.0	CHEMBL4670	Homo sapiens	% inhibition	%	-5.0
Not Active	23329408	CHEMBL4881115	MAPKAP-K3(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	113.0	CHEMBL4670	Homo sapiens	% residual kinase activity	%	113.0
Not Active	23337673	CHEMBL4882044	MAPKAPK3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.5	CHEMBL4670	Homo sapiens	% Ctrl	%	98.5
Not Active	23352125	CHEMBL4882814	MAPKAPK3 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.728	CHEMBL4670	Homo sapiens	% Inhibition	%	3.7275
Not Active	23367631	CHEMBL4883984	MAPKAPK3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	95.0	CHEMBL4670	Homo sapiens	% Residual activity with Skepinone-L	%	95.0
Not Active	23370129	CHEMBL4884373	MAPKAP-K3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	106.0	CHEMBL4670	Homo sapiens	% residual kinase activity	%	106.0
Not Active	23375027	CHEMBL4886016	MAPKAPK3 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	6.0	CHEMBL4670	Homo sapiens	% Inhibition	%	6.0
Not Active	23375294	CHEMBL4886276	mitogen-activated protein kinase-activated protein kinase 3 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	3.0	CHEMBL4670	Homo sapiens	% inhibition	%	3.0
Not Active	23383879	CHEMBL4887498	MAPKAPK3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL4670	Homo sapiens	% Ctrl	%	93.0
Not Active	23384044	CHEMBL4887642	MAPKAP-K3 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	90.2	CHEMBL4670	Homo sapiens	% Ctrl	%	90.2
Not Active	23384532	CHEMBL4888127	MAPKAP-K3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.32	CHEMBL4670	Homo sapiens	% inhibition	%	5.32
Not Active	23384671	CHEMBL4888197	MAPKAPK3 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	17.0	CHEMBL4670	Homo sapiens	% Inhibition	%	17.0
